<html>

<head>   <meta charset="utf-8" />
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 10 (filtered)">
<title>N�ROLOJ&#304;DE AC&#304;L YAKLA&#350;IM</title>

<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:Calibri;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	line-height:115%;
	font-size:11.0pt;
	font-family:Calibri;}
h1
	{margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:Arial;}
h2
	{margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	page-break-after:avoid;
	font-size:14.0pt;
	font-family:"Times New Roman";}
h4
	{margin:0cm;
	margin-bottom:.0001pt;
	line-height:150%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman";}
h5
	{margin:0cm;
	margin-bottom:.0001pt;
	line-height:150%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman";
	font-weight:normal;
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{margin:0cm;
	margin-bottom:.0001pt;
	line-height:150%;
	font-size:12.0pt;
	font-family:"Times New Roman";
	font-weight:bold;
	font-style:italic;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	line-height:115%;
	font-size:10.0pt;
	font-family:Calibri;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	line-height:115%;
	font-size:11.0pt;
	font-family:Calibri;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0cm;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman";}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	line-height:115%;
	font-size:11.0pt;
	font-family:Calibri;}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0cm;
	margin-bottom:.0001pt;
	font-size:14.0pt;
	font-family:"Times New Roman";
	font-weight:bold;}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman";}
a:link, span.MsoHyperlink
	{font-family:"Times New Roman";
	color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	line-height:115%;
	font-size:10.0pt;
	font-family:Calibri;
	font-weight:bold;}
span.Char
	{font-family:Arial;
	font-weight:bold;}
span.Char0
	{font-family:"Times New Roman";
	font-weight:bold;}
span.Char1
	{font-family:"Times New Roman";
	font-weight:bold;}
span.Char2
	{font-family:"Times New Roman";
	font-style:italic;}
span.Char3
	{font-family:"Times New Roman";
	font-weight:bold;
	font-style:italic;}
span.Char4
	{font-family:"Times New Roman";
	font-weight:bold;}
span.Char5
	{font-family:"Times New Roman";}
p.ListParagraph, li.ListParagraph, div.ListParagraph
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:36.0pt;
	line-height:115%;
	font-size:11.0pt;
	font-family:Calibri;}
p.ListParagraphCxSp\0130lk, li.ListParagraphCxSp\0130lk, div.ListParagraphCxSp\0130lk
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	line-height:115%;
	font-size:11.0pt;
	font-family:Calibri;}
p.ListParagraphCxSpOrta, li.ListParagraphCxSpOrta, div.ListParagraphCxSpOrta
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	line-height:115%;
	font-size:11.0pt;
	font-family:Calibri;}
p.ListParagraphCxSpSon, li.ListParagraphCxSpSon, div.ListParagraphCxSpSon
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:36.0pt;
	line-height:115%;
	font-size:11.0pt;
	font-family:Calibri;}
span.Char6
	{font-family:"Times New Roman";}
span.Char7
	{font-family:"Times New Roman";}
ins
	{text-decoration:none;}
span.msoIns
	{text-decoration:underline;}
span.msoDel
	{text-decoration:line-through;
	color:red;}
 /* Page Definitions */
 @page Section1
	{size:595.3pt 841.9pt;
	margin:70.85pt 70.85pt 70.85pt 70.85pt;}
div.Section1
	{page:Section1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>

</head>

<body lang=EN-US link=blue vlink=purple>

<div class=Section1>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal;page-break-after:avoid;border:none;padding:0cm'><b><span
lang=TR style='font-size:18.0pt;font-family:Tahoma'>N�ROLOJ&#304;DE AC&#304;L
YAKLA&#350;IM</span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal;border:none;padding:0cm'><span lang=TR
style='font-size:14.0pt;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal;border:none;padding:0cm'><b><span lang=TR
style='font-size:14.0pt;font-family:Tahoma'>Yakup Krespi, Ebru
Alt&#305;nda&#287;</span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal;border:none;padding:0cm'><span lang=TR
style='font-size:12.0pt;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal;border:none;padding:0cm'><span lang=TR
style='font-size:12.0pt;font-family:Tahoma'>Son g�ncelle&#351;tirme tarihi: 31.08.2009</span></p>

</div>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span lang=TR style='font-size:12.0pt;font-family:
Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%;page-break-after:avoid'><b><span lang=TR
style='font-size:14.0pt;line-height:150%;font-family:Tahoma'>G&#304;R&#304;&#350;</span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Bir genel n�roloji kitab&#305; i�ine ayr&#305;ca
&quot;n�rolojide acil yakla&#351;&#305;m&quot; ba&#351;l&#305;&#287;&#305;
alt&#305;nda bir konu katmaktaki ama� t�m n�rolojik acil hastal&#305;klar&#305;
tan&#305; ve tedavi �zellikleriyle birlikte kapsaml&#305; bir &#351;ekilde ele
almak de&#287;ildir. Bu hastal&#305;klarla ilgili de&#287;erlendirme ve tedavi
yakla&#351;&#305;mlar&#305; bu kitab&#305;n ilgili b�l�mlerinde kapsaml&#305;
bir &#351;ekilde ele al&#305;nmaktad&#305;r. Okuyucu gerekti&#287;inde bu
b�l�mlerdeki bilgilere ba&#351;vurabilir. Genel olarak bu b�l�m
haz&#305;rlan&#305;rken bir�ok genel metinde yer almayan, ancak n�rolojik acil
bir olay kar&#351;&#305;s&#305;nda hekimin davran&#305;&#351;&#305;n&#305;
belirlemesi i�in gereken esas yakla&#351;&#305;mlar&#305;n vurgulanmas&#305;
ama�lanm&#305;&#351;t&#305;r. Temel olarak acil n�rolojik olayla
kar&#351;&#305;m&#305;za gelen bir hastay&#305; h&#305;zl&#305;ca ve eksiksizce
de&#287;erlendirmemizi sa&#287;layacak sistematik yakla&#351;&#305;mlar konu
edilmeye �al&#305;&#351;&#305;lm&#305;&#351;t&#305;r. Bu b�l�mde
s&#305;ras&#305;yla a&#351;a&#287;&#305;daki konular g�zden ge�irilecektir:</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
font-family:Tahoma'>Acil n�rolojik de&#287;erlendirmenin esaslar&#305; </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
font-family:Tahoma'>Acil ve �zellikle a&#287;&#305;r n�rolojik durumlar
kar&#351;&#305;s&#305;nda &quot;ileri n�rolojik ya&#351;am deste&#287;i&quot; yakla&#351;&#305;mlar&#305;&nbsp;
</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
font-family:Tahoma'>Acil n�rolojik olaylarda tan&#305;ya gidi&#351; ve mutlak
g�zetilmesi gereken tan&#305; �ncelikleri. </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><b><span lang=TR style='font-size:14.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%;page-break-after:avoid'><b><span lang=TR
style='font-size:14.0pt;line-height:150%;font-family:Tahoma'>AC&#304;L
N�ROLOJ&#304;K DE&#286;ERLEND&#304;RMEN&#304;N ESASLARI </span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>N�rolojik acil olay kar&#351;&#305;s&#305;nda
ama�lar&#305;m&#305;z basit�e <i>&quot;ya&#351;am&#305;n idamesi&quot;</i> ve <i>&quot;n�rolojik
i&#351;levin idamesi&quot; </i>olarak �zetlenebilir. N�roloji acilinin �nemi ve
�rk�t�c�l�&#287;� ba&#351;l&#305;ca iki nedenle ortaya �&#305;kmaktad&#305;r:
Bir yandan ya&#351;amsal fonksiyonlar&#305;n normal
�al&#305;&#351;mas&#305;n&#305; sa&#287;layan, di&#287;er yandan da kendi normal
fonksiyonunu s�rd�rebilmesi bu ya&#351;amsal fonksiyonlar&#305;n
devaml&#305;l&#305;&#287;&#305;na ba&#287;l&#305; olan sinir sistemi, �nemli
veya ani hasar durumlar&#305;nda bu etkile&#351;imin birbirini
k&#305;&#351;k&#305;rtmas&#305; ile k&#305;s&#305;r d�ng�ye girer. Ortaya �&#305;kan
bu k&#305;s&#305;r d�ng� ikincil n�rolojik veya di&#287;er ikincil organ
hasarlar&#305;n&#305;n ortaya �&#305;kmas&#305;na neden olur.&nbsp; <i>N�rolojik
hasar sonras&#305; geli&#351;en sistemik k&#305;s&#305;r d�ng�n�n �nlenmesi
tedavisinden daha kolayd&#305;r ve bunun i�in gereken s�re de olduk�a
s&#305;n&#305;rl&#305;d&#305;r.</i></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>N�rolojik tutulumu olan hastaya geleneksel
bak&#305;&#351; kaderci bir bak&#305;&#351; a�&#305;s&#305;d&#305;r. N�rolojik
aciller de i�inde olmak �zere bir�ok n�rolojik hastal&#305;kta tedavi
yakla&#351;&#305;mlar&#305;n&#305;n k&#305;s&#305;tl&#305; oldu&#287;u
�&#287;retisi ve san&#305;s&#305; bu hastalara etkin yakla&#351;&#305;m&#305;
engelleyen en temel nedendir. En �nemli yan&#305;lg&#305;lardan biri bu tip
hastalar kar&#351;&#305;s&#305;nda hastay&#305; de&#287;erlendirmek
a�&#305;s&#305;ndan yeterli zamana sahip oldu&#287;umuzdur. </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Klasik n�rolojik de&#287;erlendirme kapsaml&#305; bir �yk�
ve n�rolojik muayene esas&#305;na dayan&#305;r. Bu kapsaml&#305;
de&#287;erlendirmeden sonra, elde edilen bulgulara dayanan geleneksel lezyon
lokalizasyonu egzersizi gelmektedir. Bu yakla&#351;&#305;m genel n�roloji
poliklini&#287;inde �ok faydal&#305; olmas&#305;na ra&#287;men bir�ok acil
n�rolojik hastal&#305;kta yetersiz ve �nemli bir zaman kayb&#305; nedenidir.
Klasik detayl&#305; n�rolojik de&#287;erlendirme �zellikle a&#287;&#305;r
n�rolojik hasarl&#305; hastada genellikle �nemli bir zaman kayb&#305;na neden
olur.&nbsp;Yukar&#305;da �zetlemeye �al&#305;&#351;t&#305;&#287;&#305;m&#305;z
ve birbirleriyle �eli&#351;en ger�ekler n�rolojik acil olay
kar&#351;&#305;s&#305;nda yakla&#351;&#305;mlar&#305;m&#305;z&#305; tekrardan
g�zden ge�irmemizi gerektirmektedir. Yakla&#351;&#305;mlar&#305;m&#305;z
a&#351;a&#287;&#305;da s&#305;ralanan ilkeler &#305;&#351;&#305;&#287;&#305;nda
tekrar &#351;ekillenmelidir. Kapsaml&#305; bir hastal&#305;k �yk�s� olmadan da
acil n�rolojik de&#287;erlendirme ve destek tedavileri
ba&#351;lat&#305;lmal&#305;d&#305;r. Hayat&#305; ve n�rolojik fonksiyonu tehdit
eden durum ilk �nce tedavi edilmelidir. Kesin tan&#305;ya
ula&#351;&#305;lmam&#305;&#351; olmas&#305; uygun destek tedavilerinin
ba&#351;lat&#305;lmas&#305;n&#305;n yan&#305; s&#305;ra olas&#305; ve tedavi
edilmezse prognozu k�t�le&#351;tirecek tan&#305;ya y�nelik spesifik tedavinin
ba&#351;lat&#305;lmas&#305;n&#305; da geciktirmemelidir.</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%;page-break-after:avoid'><b><span lang=TR
style='font-size:14.0pt;line-height:150%;font-family:Tahoma'>&#304;LER&#304;
N�ROLOJ&#304;K YA&#350;AM DESTE&#286;&#304; YAKLA&#350;IMLARI</span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Acilde a&#287;&#305;r n�rolojik tablolar
kar&#351;&#305;s&#305;nda sahip oldu&#287;umuz k&#305;s&#305;tl&#305; bir s�re
i�inde, klinik tablo ne olursa olsun, sinir sistemi hangi d�zeyinde
hastalanm&#305;&#351; olursa olsun, �ncelikle ve h&#305;zl&#305;ca genel acil
prensiplerinin uygulanmas&#305; gerekmektedir. �o&#287;unlukla
de&#287;i&#351;ik derecelerde bilin� bozuklu&#287;u ile
kar&#351;&#305;m&#305;za �&#305;kan bu hastalarda ana prensip, hastan&#305;n
ya&#351;amsal fonksiyonlar&#305;ndan sorumlu oldu&#287;umuzun bilincinde
olmam&#305;zd&#305;r. Bu nedenle hastan&#305;n solunum yolunun a�&#305;k
tutulmas&#305; (a&#287;&#305;z yolu, int�basyon, trakeostomi), gerekli
oksijenizasyonun sa&#287;lanmas&#305; (nazal oksijen, vs.), ve hemodinamik
stabilitenin sa&#287;lanmas&#305; en �nemli �nceliktir. Klasik olarak ABC
(A=airway, B=breathing, C=circulation) &#351;eklinde �zetlenen bu �ncelikli
yakla&#351;&#305;mlar uygulan&#305;rken hasta e&#351;zamanl&#305; olarak
a&#351;a&#287;&#305;da belirtilen temel prensipler
&#305;&#351;&#305;&#287;&#305;nda h&#305;zl&#305;ca n�rolojik a�&#305;dan
de&#287;erlendirilecek ve gerekli laboratuvar incelemeleri
yap&#305;lacakt&#305;r. N�rolojik de&#287;erlendirme ve n�rolojik hasar&#305;
s&#305;n&#305;rland&#305;rmaya y�nelik giri&#351;imleri de i�ine alan �ncelikli
yakla&#351;&#305;m&#305; ABCD (D=deficit) &#351;eklinde �zetleyebiliriz.
&#304;leri kardiyak sorunlu veya travmal&#305; hastada, ya&#351;am
deste&#287;inde oldu&#287;u gibi acil n�roloji prati&#287;inde standart hale
getirilerek uygulanacak &quot;<i>ileri n�rolojik ya&#351;am deste&#287;i
yakla&#351;&#305;mlar&#305;</i>&quot;, bir�ok a&#287;&#305;r n�rolojik
hastal&#305;k durumunda ortaya �&#305;kan ve s�rmekte olan n�rolojik
hasar&#305;n s&#305;n&#305;rland&#305;r&#305;lmas&#305;n&#305; sa&#287;layacakt&#305;r.&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><b><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%;page-break-after:avoid'><b><span lang=TR
style='font-size:14.0pt;line-height:150%;font-family:Tahoma'>Hava Yolu-Solunum
Deste&#287;i&nbsp; </span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>N�rolojik aciller esnas&#305;nda en s&#305;k
kar&#351;&#305;la&#351;&#305;lan ve solunumu ilgilendiren sorunlar; hava yolu
a�&#305;kl&#305;&#287;&#305;n&#305;n korunmas&#305;, ventilasyonun
sa&#287;lanmas&#305; ve aspirasyonun �nlenerek uygun oksijenizasyonun
sa&#287;lanmas&#305;d&#305;r. Normal ventilasyon, solunum kaslar&#305; ile �st
solunum yolu kaslar&#305;n&#305;n normal mekani&#287;i ve koordine fonksiyonu
sonucunda sa&#287;lan&#305;r.&nbsp; </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Bir�ok akut n�rolojik olay sonras&#305;nda �st solunum
yolu kaslar&#305;ndaki anormal aktivite �st solunum yollar&#305;n&#305;n
kollabe olmas&#305;na ve bu yollar&#305;n koruyucu reflekslerinin ortadan
kalkmas&#305;na yol a�ar. Bu durum, bu yollar&#305;n
a�&#305;kl&#305;&#287;&#305;n&#305;n korunmas&#305;na y�nelik
ger�ekle&#351;tirilen endotrakeal int�basyonun en �nemli nedenidir.&nbsp;
Miyastenia gravis (MG), Guillain-Barr� sendromu (GBS) veya amiyotrofik lateral
sklerozda (ALS) oldu&#287;u gibi solunum kaslar&#305; zaaf&#305;na
ba&#287;l&#305; olarak ventilasyon yetersizli&#287;i geli&#351;ebilir.&nbsp;
Akut metabolik bozukluk veya intoksikasyonlar sonucu geli&#351;en akut
ensefalopatiler veya beyinsap&#305; tutulmas&#305;na ba&#287;l&#305; olarak
solunum merkezi deprese olabilir veya anormal solunum paternleri
geli&#351;ebilir ve bunun sonucunda ventilasyon bozulabilir. Akut n�rolojik
tabloya e&#351;lik edebilecek akut akci&#287;er hastal&#305;klar&#305; da
solunum yetmezli&#287;ine yol a�abilir.</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>�</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Neden ne olursa olsun solunum tedavisinin ilk
basama&#287;&#305; olan hava yolunun a�&#305;kl&#305;&#287;&#305;n&#305;n
h&#305;zl&#305;ca sa&#287;lanamamas&#305;, bu a�&#305;kl&#305;&#287;&#305;n
s�rd�r�lememesi bir�ok hastan&#305;n daha da k�t�le&#351;mesine neden
olabilir.&nbsp; Hava yolu a�&#305;kl&#305;&#287;&#305;n&#305;n sa&#287;lanmas&#305;
uzmanl&#305;k gerektiren ve yaln&#305;zca yo&#287;un bak&#305;m
uzmanlar&#305;nca uygulanabilen bir giri&#351;im de&#287;ildir. Acilde g�rev
alan her hekim, n�rolojik muayene konusunda sahip oldu&#287;u beceriler ne
olursa olsun, hava yolunu a�abilmeli ve bu a�&#305;kl&#305;&#287;&#305; uzman
yard&#305;m gelene dek devam ettirebilmelidir. Hi� bir hasta hava yolu
g�venli&#287;i sa&#287;lanmadan kranyal g�r�nt�leme incelemelerine
g�nderilmemelidir. Tan&#305; i&#351;lemleri tamamlanana dek k&#305;sa s�reli de
olsa int�basyon ve ventilasyon karar&#305;n&#305;n al&#305;nmas&#305;nda gecikilmemelidir.</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%;page-break-after:avoid'><b><i><span lang=TR
style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>&nbsp;</span></i></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%;page-break-after:avoid'><b><i><span lang=TR
style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>Hava yolu </span></i></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Uygun oksijenizasyonun sa&#287;lanmas&#305;nda ilk
basamak hava yolu a�&#305;kl&#305;&#287;&#305;n&#305;n
sa&#287;lanmas&#305;d&#305;r. Endotrakeal int�basyon d&#305;&#351;&#305;nda
bir�ok y�ntemle hava yolu a�&#305;kl&#305;&#287;&#305; sa&#287;lanabilir. Bu
y�ntemler �zellikle endotrakeal int�basyonun h&#305;zl&#305;ca
yap&#305;lamad&#305;&#287;&#305; durumlarda zaman kazanmak a�&#305;s&#305;ndan
her hekimin kolayca uygulayabilece&#287;i y�ntemlerdir ve hayat
kurtar&#305;c&#305;d&#305;r. Uygulanan metod ne olursa olsun, �zellikle uzun
s�re hava yolu a�&#305;kl&#305;&#287;&#305;n&#305; devam ettiremeyecek
�rne&#287;in komal&#305; hastalarda mutlaka endotrakeal t�p gerekecektir. </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span lang=TR style='font-size:12.0pt;font-family:
Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%;page-break-after:avoid'><b><i><span lang=TR
style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>�enenin
kald&#305;r&#305;lmas&#305; tekni&#287;i</span></i></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Hastan&#305;n boynu hiperekstansiyona getirilerek,
bazen de boyun immobilizasyonu uygulanm&#305;&#351; hastalarda tek
ba&#351;&#305;na uygulanabilir. Hekim her iki elinin parmaklar&#305;yla
hastan&#305;n �enesini kavrar ve �ne do&#287;ru kald&#305;r&#305;r. Boyun
hiperekstansiyona getirilecekse bir elle ba&#351; al&#305;ndan itilerek hiperekstansiyona
getirilirken di&#287;er elle �ene ucundan kavranarak �ne ve yukar&#305;ya
do&#287;ru kald&#305;r&#305;l&#305;r <b>(&#350;ekil 1).</b> Bu s&#305;rada
ba&#351;ka birinden ba&#351;&#305;n ekstansiyonda kalmas&#305; i�in yard&#305;m
al&#305;narak bir elle �ene yukar&#305;da tutulurken di&#287;er elle
a&#287;&#305;z ve orofarinks b�lgesi yabanc&#305; cisimlerden temizlenebilir ve
aspirasyon uygulanabilir <b>(&#350;ekil 2)</b>. Bu s&#305;rada takma
di&#351;ler �&#305;kar&#305;lmal&#305;d&#305;r. Bu i&#351;lemler
s&#305;ras&#305;nda �zellikle yeni bir epileptik n�bet ge�irmi&#351; hastada
oro-faringeal hava yolu tak&#305;lmas&#305; �nem kazan&#305;r. Bu y�ntem
olas&#305; yeni bir n�bet esnas&#305;nda hastan&#305;n dilini
&#305;s&#305;rmas&#305;n&#305; engelleyecektir. Hava yolu yerle&#351;tirilirken
�&#287;�rme refleksi olan hastalarda �ok dikkatli olunmal&#305;d&#305;r, ��nk�
b�yle hastalar kusup aspire edebilirler.&nbsp; Hastalara a&#287;&#305;z
kommis�r� ile tragus aras&#305;ndaki mesafeden daha uzun hava yolu
yerle&#351;tirilmemelidir.</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
lang=TR style='font-family:Tahoma'><a href="acil1.jpg"><b><span
style='font-size:10.0pt'>&#350;ekil 1.</span></b><span style='font-size:10.0pt;
color:windowtext;text-decoration:none'> �enenin kald&#305;r&#305;lmas&#305;.</span></a></span><span
lang=TR style='font-size:10.0pt;font-family:Tahoma'> �ene �ne do&#287;ru
�ekilir ve hastan&#305;n ba&#351;&#305; arkaya do&#287;ru itilerek
hiperekstansiyona getirilir (Kaynak 5�ten al&#305;nm&#305;&#351;t&#305;r). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
lang=TR style='font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
lang=TR style='font-family:Tahoma'><a href="acil2.jpg"><b><span
style='font-size:10.0pt'>&#350;ekil 2.</span></b><b><span style='font-size:
10.0pt;text-decoration:none'> �</span></b><span style='font-size:10.0pt;
color:windowtext;text-decoration:none'>A&#287;z&#305;n temizlenmesi.</span></a></span><span
lang=TR style='font-size:10.0pt;font-family:Tahoma'> Boyun hiperekstansiyona
getirildikten sonra a&#287;z&#305;n i�i temizlenir (Kaynak 5�ten
al&#305;nm&#305;&#351;t&#305;r).</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>T�m bu giri&#351;imlerin
yararl&#305;l&#305;&#287;&#305;, hastan&#305;n toraks&#305; g�zlenerek yeterli
ve normal solunum hareketlerinin varl&#305;&#287;&#305;, her iki hemitoraks
dinlenerek solunum seslerinin varl&#305;&#287;&#305;, normal ve simetrik
olu&#351;u ve e&#287;er hastan&#305;n parmaktan O2 sat�rasyonu s�rekli olarak
izlenebiliyorsa oksijen sat�rasyonunun en az&#305;ndan %90'&#305;n (PO2=70mmHg)
�zerinde tutulmas&#305; ile anla&#351;&#305;labilir. Siyanozun gerilemesi,
t&#305;rnak yataklar&#305;, deri ve mukozan&#305;n normal pembe rengine
d�nmesi, ta&#351;ikardi ve takipnenin gerilemesi iyi oksijenizasyonun en �nemli
g�stergeleridir. Bu i&#351;lemlere ra&#287;men stridor ve g�zlenebilecek
paradoksal solunum daha distal obstr�ksiyonu d�&#351;�nd�rmelidir. Bu durumda
derin trakeal aspirasyon ve &#351;artlar elveri&#351;li ise endoskopik
aspirasyon yap&#305;lmal&#305;d&#305;r. Gerekli oksijenizasyon
sa&#287;lanam&#305;yorsa int�basyon ve ventilasyon sa&#287;lanana dek maske ile
s�rekli 10-15 lt/dakika olacak &#351;ekilde %100 oksijen verilip ambu ile hasta
ventile edilmelidir. Bu yolla yakla&#351;&#305;k %90-100'l�k bir FiO2'ye
ula&#351;&#305;labilir (<b>&#350;ekil 3</b>).</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
lang=TR style='font-size:10.0pt;font-family:Tahoma'>�</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
lang=TR style='font-family:Tahoma'><a href="acil3.jpg"><b><span
style='font-size:10.0pt'>&#350;ekil 3. </span></b><span style='font-size:10.0pt;
color:windowtext;text-decoration:none'>Maske ile ambulama</span></a> </span><span
lang=TR style='font-size:10.0pt;font-family:Tahoma'>(Kaynak 5�ten
al&#305;nm&#305;&#351;t&#305;r). </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Hava yolu a�&#305;lm&#305;&#351; olan hastalarda
ventilasyonun yeterli oldu&#287;una ve yeterli oksijen sat�rasyonu
sa&#287;lanabildi&#287;ine dikkat edilmelidir. Hastalarda optimal
oksijenizasyonun s�rd�r�lmesi i�in ek O2 tedavisi gerekli olabilir. �zellikle
bilin� bozuklu&#287;u olan hastalarda hipoksemi ile m�cadele tedavide en �nemli
basamakt&#305;r. N�rolojik acillerde hipoksemi nedeni �ok �e&#351;itli olabilir
ve neden hakk&#305;nda hasta g�r�ld�&#287;� s&#305;rada karar verilemeyebilir.
Olas&#305; nedenler aras&#305;nda aspirasyon, anormal solunum paternleri
(Cheyne-Stokes vs) ve pulmoner �dem gibi durumlar say&#305;labilir. </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Spontan olarak soluk al&#305;p verebilen bir hastada
solunan havadaki O2 miktar&#305;n&#305; artt&#305;rmak ek O2 tedavisi ile
m�mk�nd�r. Oksijen konsantrasyonu (FiO2) O2 debisine ve verili&#351; yoluna
ba&#287;l&#305;d&#305;r. Her 1lt/dakikal&#305;k O2 debisi ile solunan havadaki
O2 0,04 katsay&#305;s&#305; oran&#305;nda artt&#305;r&#305;l&#305;r (2lt/dakika
O2=%28 FiO2, 5lt/dakika 02=%40 FiO2). Y�ze tam olarak yap&#305;&#351;mayan
maske ve 5-8lt/dakika O2 ile %40-60 FiO2 sa&#287;lamak m�mk�nd�r. E&#287;er
maske rezervuarl&#305; ise 6-10lt/dakika O2 ile %80'e yak&#305;n FiO2
sa&#287;lanabilir. Maske ve ambu ile 10-15lt/dakika O2 ile %100'l�k bir FiO2'ye
ula&#351;&#305;labilir. Nazal kan�l yoluyla 3-4 lt/dakika olarak yap&#305;lan
O2 tedavileri genellikle yeterli de&#287;ildir, yaln&#305;zca %30'luk bir O2
konsantrasyonuna ula&#351;&#305;labilir. Kan�l kolayl&#305;kla yerinden
�&#305;kabilir. Kan�l yoluyla yap&#305;lan O2 tedavisinde kateter ancak
orofarinks d�zeyinden g�r�lebilecek &#351;ekilde yerle&#351;tirilebilirse maske
ile olana benzer O2 konsantrasyonuna ula&#351;&#305;labilir. Gerek kan�l
gerekse de maske ile yap&#305;lan O2 tedavilerinde, bunlar&#305;n s&#305;k
s&#305;k uygun &#351;ekilde durduklar&#305;na dikkat edilmelidir.</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>�</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Ek oksijen tedavisi uygulanan hastalarda, �zellikle
obstr�ktif akci&#287;er hastal&#305;&#287;&#305; anamnezi varsa, solunum
depresyonu ile birlikte hiperkapni ve buna ba&#287;l&#305; olarak hiperkapnik
ensefalopati geli&#351;imi riski a�&#305;s&#305;ndan dikkatli
olunmal&#305;d&#305;r. Hastalar klinik olarak izlenmeli; sedasyon, siyanoz,
terleme ve apneik bir solunum geli&#351;imi a�&#305;s&#305;ndan g�zlenmeli ve
m�mk�nse kontrol kan gaz&#305; incelemeleri yap&#305;larak hiperkapni geli&#351;ip
geli&#351;medi&#287;i g�r�lmelidir. </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%;page-break-after:avoid'><b><i><span lang=TR
style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>Endotrakeal
int�basyon ve ventilasyon&nbsp; </span></i></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Endotrakeal int�basyon uygulama indikasyonlar&#305;
geni&#351; tutulmal&#305;d&#305;r. �zellikle hava yolunun g�venli&#287;i risk
alt&#305;nda ve ventilasyon indikasyonu oldu&#287;unda uygulan&#305;r. Bu
y�ntemin bir�ok avantajlar&#305; vard&#305;r: </span></p>

<p class=ListParagraphCxSp&#304;lk style='margin-bottom:0cm;margin-bottom:.0001pt;
text-align:justify;text-indent:-36.0pt;line-height:150%'><span lang=TR
style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=TR style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>Hava yolu
izole edilir, b�ylece yeni aspirasyon riski azalt&#305;l&#305;r. </span></p>

<p class=ListParagraphCxSpOrta style='margin-bottom:0cm;margin-bottom:.0001pt;
text-align:justify;text-indent:-36.0pt;line-height:150%'><span lang=TR
style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=TR style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>Ventilasyon
ve oksijenizasyonu kolayla&#351;t&#305;r&#305;r. </span></p>

<p class=ListParagraphCxSpOrta style='margin-bottom:0cm;margin-bottom:.0001pt;
text-align:justify;text-indent:-36.0pt;line-height:150%'><span lang=TR
style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>3.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=TR style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>Trakea ve
bron&#351;lardaki sekresyonlar daha kolay aspire&nbsp; edilebilir. </span></p>

<p class=ListParagraphCxSpSon style='margin-bottom:0cm;margin-bottom:.0001pt;
text-align:justify;text-indent:-36.0pt;line-height:150%'><span lang=TR
style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>4.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=TR style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>Baz&#305;
ila�lar&#305;n kullan&#305;m&#305; bu yolla ger�ekle&#351;tirilebilir. </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&#304;nt�basyon bu konuda deneyimli ki&#351;ilerce
uygulanmal&#305;d&#305;r. Acilde hekim int�basyon ve ventilasyon konusunda
yeterli deneyime sahip de&#287;ilse bile en az&#305;ndan bu tedavinin
indikasyonlar&#305;n&#305; koyabilecek kadar bilgiye sahip olmal&#305;d&#305;r.</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp; </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>N�roloji acilinde int�basyon ve mekanik ventilasyon
indikasyonlar&#305; <b>Tablo 1</b>�deki gibi �zetlenebilir. N�roloji acilindeki
indikasyonlar&#305;n b�y�k �o&#287;unlu&#287;u hava yolunun stabilize edilmesi
ve ventilasyonun sa&#287;lanmas&#305; amac&#305;na y�neliktir. Akci&#287;er
kaynakl&#305; indikasyonlar (masif aspirasyon, akut n�rolojik pulmoner �dem
gibi) g�receli olarak daha nadirdir. <i>Oksijenizasyon bozuklu&#287;u
a�&#305;s&#305;ndan mekanik ventilasyon indikasyonu basit�e uygun bir O2
sat�rasyonunu (%90) s�rd�rebilmek amac&#305;yla %50-60'l&#305;k bir FiO2 ile
oksijen s�plementasyonu yapma gereksiniminin do&#287;mas&#305;d&#305;r (maske
ile 7-8lt/dakika uygulama gereklili&#287;i).</i></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=631
 style='width:473.4pt;border-collapse:collapse;border:none'>
 <tr>
  <td width=631 valign=top style='width:473.4pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoBodyText style='text-align:justify'><b><span lang=TR
  style='font-size:12.0pt;line-height:115%;font-family:Tahoma'>Tablo 1.
  N�roloji acilinde int�basyon ve mekanik ventilasyon indikasyonlar&#305;</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=631 valign=top style='width:473.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoBodyText style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:54.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:
  -54.0pt;line-height:150%'><span lang=TR style='font-family:Symbol'>�<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Hipoventilasyon ve
  apneik solunum: Her t�rl� ensefalopati seyrinde, beyinsap&#305;
  tutulmas&#305; </span></p>
  <p class=MsoBodyText style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:54.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:
  -54.0pt;line-height:150%'><span lang=TR style='font-family:Symbol'>�<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Solunum
  kaslar&#305;n&#305;n tutuldu&#287;u primer n�rom�sk�ler zaaf: MG, ALS, GBS vs.
  </span></p>
  <p class=MsoBodyText style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:54.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:
  -54.0pt;line-height:150%'><span lang=TR style='font-family:Symbol'>�<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Hava yolu
  g�venli&#287;inin sa&#287;lanmas&#305;n&#305;n zor oldu&#287;u durumlar:
  Uyan&#305;kl&#305;&#287;&#305;n ileri derecede bozuldu&#287;u </span><span
  lang=TR style='font-family:Symbol'>[</span><span lang=TR style='font-family:
  Tahoma'>Glasgow koma skorunun (GKS) 8 ve alt&#305;nda oldu&#287;u</span><span
  lang=TR style='font-family:Symbol'>]</span><span lang=TR style='font-family:
  Tahoma'> durumlar �r: a&#287;&#305;r inmeli hastalar </span></p>
  <p class=MsoBodyText style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:54.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:
  -54.0pt;line-height:150%'><span lang=TR style='font-family:Symbol'>�<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Y�ksek servikal medulla
  spinalis tutulumu </span></p>
  <p class=MsoBodyText style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:54.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:
  -54.0pt;line-height:150%'><span lang=TR style='font-family:Symbol'>�<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>K&#304;BAS'da
  hiperventilasyon amac&#305;yla </span></p>
  <p class=MsoBodyText style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:54.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:
  -54.0pt;line-height:150%'><span lang=TR style='font-family:Symbol'>�<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Status epileptikus
  (SE) </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
lang=TR style='font-size:10.0pt;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
lang=TR style='font-size:10.0pt;font-family:Tahoma'>N�rolojik int�basyon ve
ventilasyon indikasyonlar&#305; aras&#305;nda en karma&#351;&#305;klar&#305;ndan
biri n�rom�sk�ler zaaf&#305; olan hastalar ve �zellikle miyastenik
hastalard&#305;r. Acile gelen MG'li veya GBS'i olan hastalarda hekim ne zaman
int�basyon ve ventilasyon indikasyonu ortaya �&#305;kt&#305;&#287;&#305;n&#305;
�ok iyi bilmelidir.� <b>N�rom�sk�ler acillerde int�basyon ve ventilasyon
indikasyonu arter kan gaz&#305; veya O2 sat�rometri �parametreleri ile
de&#287;il klinik de&#287;erlendirme sonunda konulur. Bu tip hastalar daha O2
sat�rasyonu d�&#351;meden, hiperkapni geli&#351;meden, yard&#305;mc&#305;
solunum kaslar&#305; solunuma kat&#305;lmadan, paradoksal solunum
geli&#351;meden de solunum yetersizli&#287;i i�inde olabilirler ve
h&#305;zl&#305;ca akut solunum yetersizli&#287;ine girebilirler (Tablo 2).</b>
Ta&#351;ikardi, takipne, s�rekli soluklanmak amac&#305;yla konu&#351;man&#305;n
kesik kesik olmas&#305;, minimal bir eksersiz sonras&#305;nda soluk solu&#287;a
kal&#305;nmas&#305;, horizontal pozisyonun iyi tolere edilememesi ve hemen
takipne geli&#351;mesi, sat�rometri ile izleniyorlarsa k&#305;sa s�reli
desat�rasyon d�nemleri g�zlenmesi, tek soluk al&#305;&#351;ta birden 20'ye
kadar say&#305;lamamas&#305; (genellikle vital kapasitelerinin 15-18ml/kg veya
alt&#305;na d�&#351;t�&#287;�n�n bir g�stergesidir), sabah yorgunlu&#287;u,
ba&#351; a&#287;r&#305;s&#305; ve g�nd�z uyuklamalar&#305; (gece boyunca apne
n�betlerinin ve buna ba&#287;l&#305; geli&#351;en hiperkapninin bir
g�stergesidir) haz&#305;rlanmakta olan solunum yetmezli&#287;inin en �nemli
belirtileridir. Bu bulgular&#305; olan hastalar �ok yak&#305;n g�zlenmeli ve
her an int�be ve ventile edilebilecek &#351;ekilde izlenmelidirler.</span><span
lang=TR style='font-size:12.0pt;font-family:Tahoma'> </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
lang=TR style='font-size:10.0pt;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><b><u><span
lang=TR style='font-size:10.0pt;font-family:Tahoma'><span style='text-decoration:
 none'>&nbsp;</span></span></u></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><b><u><span
lang=TR style='font-size:10.0pt;font-family:Tahoma'><span style='text-decoration:
 none'>&nbsp;</span></span></u></b></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=619 valign=top style='width:464.4pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <h1 style='text-align:justify'><span lang=TR style='font-size:12.0pt;
  font-family:Tahoma'>Tablo 2. N�rom�sk�ler hastal&#305;klarda solunum
  yetersizli&#287;inin bulgular&#305;</span></h1>
  </td>
 </tr>
 <tr>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Ta&#351;ikardi
  &gt;100/dk&nbsp; </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Takipne &gt; 20/dk</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>S�rekli soluklanmak
  amac&#305;yla konu&#351;man&#305;n kesik kesik olmas&#305; </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Minimal bir eksersiz
  sonras&#305;nda soluk solu&#287;a kal&#305;nmas&#305; </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Horizontal pozisyonun
  iyi tolere edilememesi ve hemen takipne geli&#351;mesi </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='line-height:150%;font-family:Tahoma'>Hasta
  s</span><span lang=TR style='font-family:Symbol;display:none'>�</span><span
  lang=TR style='font-family:Tahoma'>at�rometri ile izleniyorsa k&#305;sa
  s�reli desat�rasyon d�nemlerinin g�zlenmesi </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Tek solukta 1�den
  20'ye kadar say&#305;lamamas&#305; (genellikle vital kapasitelerinin
  15-18ml/kg veya alt&#305;na d�&#351;t�&#287;�n�n bir g�stergesidir) </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Sabah yorgunlu&#287;u,
  ba&#351; a&#287;r&#305;s&#305; ve g�n i�inde uyuklamalar&nbsp; </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Al&#305;nda terleme</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Yard&#305;mc&#305;
  solunum kaslar&#305;n&#305;n (sternokleidomastoid ve skalen)
  kullan&#305;lmas&#305;</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Asenkron (paradoksal)
  nefes alma</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
lang=TR style='font-size:10.0pt;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
lang=TR style='font-size:10.0pt;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
lang=TR style='font-size:10.0pt;font-family:Tahoma'>�zellikle alt yap&#305;
sorunlar&#305; olan kurumlarda int�basyonun en tart&#305;&#351;mal&#305;
indikasyonlardan biri uyan&#305;kl&#305;k durumu bozuk olan hastalardaki
uygulamad&#305;r. Teorik olarak &quot;a&#287;r&#305;y&#305; lokalize edemeyecek
kadar uyan&#305;kl&#305;&#287;&#305; bozulmu&#351; olan &quot; yani Glasgow
Koma Skoru (GKS) 8 ve alt&#305;nda olan hastalarda int�basyon hava yolu
g�venli&#287;ini sa&#287;lamaya y�nelik en �nemli giri&#351;imdir. Bu tip
hastalarda uygulanan ve bir anlamda &quot;profilaktik&quot; ama�l&#305; olan bu
tedavi aspirasyon pn�monisi, atelektazi ve pn�moni riskini ileri �l��de
azalt&#305;r. Bir�ok hastada int�be edildikten sonra mekanik ventilasyon
deste&#287;i uygulanmak zorundad&#305;r. Bunun nedeni int�basyon
s&#305;ras&#305;nda sedatif ve k�rarizan ila�lar&#305;n
kullan&#305;lmas&#305;d&#305;r. Hava yolunu a�&#305;k tutamayacak derecede
uyan&#305;kl&#305;&#287;&#305; bozuk hastalar&#305;n b�y�k �o&#287;unlu&#287;u
int�basyon sondas&#305; tak&#305;ld&#305;ktan ve sedatiflerle k�rarizan
ila�lar&#305;n etkileri ge�tikten sonra rahatl&#305;kla spontan olarak yeterli
bir &#351;ekilde ventile edebilir ve yeterli bir oksijenasyon
sa&#287;layabilirler. Di&#287;er hastalarda da s&#305;n&#305;rl&#305; bir
solunum deste&#287;i vermek gerekecektir. Yo&#287;un bak&#305;m olanaklar&#305;
k&#305;s&#305;tl&#305; olan kurumlarda hastalar tan&#305; konulana dek hava
yolu g�venli&#287;ini sa&#287;lamak amac&#305;yla int�be edilmeli, en
az&#305;ndan sedatiflerin ve k�rarizan ila�lar&#305;n etkileri ge�ene dek
genelde transport ama�l&#305; kullan&#305;lan respirat�rlerle ventile
edilmelidir. Daha sonra spontan solunumun geri d�nmesiyle e&#287;er iyi tolere
edebiliyorlarsa int�basyon sondas&#305; yerinde b&#305;rak&#305;larak tedavilerine
bir s�re daha devam edilebilir. Bu durumda en �nemli sorun int�basyon
sondas&#305;n&#305;n distal ucunun t&#305;kanmas&#305;n&#305; engelleyecek bir
bak&#305;m&#305;n uygulanabilmesidir. E&#287;er ent�basyon sondas&#305; tolere
edilemezse tekrar sedasyon gerekece&#287;inden mekanik ventilasyon
ihtiyac&#305; do&#287;acakt&#305;r. Bu durumda, solunum destek ihtiyac&#305;
olan hastalar&#305;n transport aletinden ayr&#305;l&#305;p uygun tipte
ventilat�rle tedaviye al&#305;nacaklar&#305; bir yo&#287;un bak&#305;m
merkezine g�nderilmeleri gerekir.</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
lang=TR style='font-size:10.0pt;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&#304;nt�be edilen hastalarda mekanik ventilasyon
uygulanacakt&#305;r. Bir�ok hastada yo&#287;un bak&#305;m ko&#351;ullar&#305;nda
izlenmeye ba&#351;lay&#305;ncaya dek transport respirat�r� ile ventile edilmeye
ba&#351;lan&#305;r. </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Respirat�rde genellikle ventilasyon modu&nbsp;CMV�ye (continue
mandatory ventilation), solunum h&#305;z&#305;: 8-12/dakika�ya, tidal
vol�m&nbsp;10-15ml/kg�a, FiO2 0.4-0.9, PEEP 2-5 cmH2O, inspiryum/ekspiryum 1:3
olarak ayarlan&#305;r.</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>E&#287;er hastada intrakraniyal bas&#305;n�
art&#305;&#351;&#305;na y�nelik hiperventilasyon tedavisi yap&#305;lacaksa
25-30 mmHg PCO2 elde etmek amac&#305;yla solunum h&#305;z&#305;
artt&#305;r&#305;lacakt&#305;r (14-20/dakika, genellikle 16/dakika). �Bu ama�la
solunum say&#305;s&#305; ile beraber tidal vol�m de barotravma riskinin
artmas&#305; nedeniyle artt&#305;r&#305;lmamal&#305;d&#305;r. Hasta g�nl�k
akci&#287;er direk grafisi ile takip edilmelidir. Hiperventilasyon tedavisi �ok
dikkatli ve yerinde kullan&#305;lmal&#305;d&#305;r. Yol a�t&#305;&#287;&#305;
respiratuar alkaloz nedeniyle n�bet aktivitesine ve status epileptikusun (SE)
refrakter hale gelmesine, vazokonstriksiyon nedeniyle de serebral iskemide
art&#305;&#351;a yol a�abilece&#287;i hep ak&#305;lda tutulmal&#305;d&#305;r. </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%;page-break-after:avoid'><b><i><span lang=TR
style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>Aspirasyonun
�nlenmesi </span></i></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>N�rolojik acil durumlar&#305;nda hekimi en �ok
u&#287;ra&#351;t&#305;ran ve �zenle de&#287;erlendirilmesi gereken sorunlardan
biri de hastan&#305;n aspirasyon riski olup olmamas&#305;d&#305;r (<b>Tablo 3</b>).
�zellikle uyan&#305;kl&#305;&#287;&#305; bozuk olan hastalarda s�rekli bir
aspirasyon riski s�z konusudur (<b>Tablo 4</b>). Y�ksek aspirasyon riski
ta&#351;&#305;yan hastalarda al&#305;nmas&#305; gereken en �nemli �nlem
hastan&#305;n yat&#305;&#351; pozisyonuna dikkat edilmesidir (<b>Tablo 5</b>).
�zellikle bilin� bozuklu&#287;u olan hastalarda dek�bitus laterale veya
yar&#305; oturur yat&#305;&#351; &#351;ekli en g�venli yatak
pozisyonlar&#305;d&#305;r. Hastalara orofaringeal yol veya nazogastrik sonda
uygulan&#305;rken farinks duvar&#305;n&#305;n iritasyonuna ve bu nedenle
kusmaya yol a�mamal&#305;d&#305;r. Mutlaka a&#287;&#305;zda biriken
sekresyonlar s�rekli aspire edilmelidir. Yutkunma bozuklu&#287;u olan veya
aspire etmi&#351; oldu&#287;u bilinen hastalarda ate&#351; saptan&#305;rsa
aspirasyon pn�monisi a�&#305;s&#305;ndan h&#305;zl&#305;ca
de&#287;erlendirilmeli ve uygun antibiyotik tedavi
ba&#351;lat&#305;lmal&#305;d&#305;r (<b>Tablo 6</b>). </span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=619 valign=top style='width:464.4pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><b><span lang=TR style='font-size:12.0pt;
  line-height:150%;font-family:Tahoma'>&nbsp;</span></b></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><b><span lang=TR style='font-size:12.0pt;
  line-height:150%;font-family:Tahoma'>Tablo 3. Hangi hastalarda aspirasyon
  riski vard&#305;r?</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
  150%;font-family:Tahoma'>�<b>Klinik duruma g�re</b></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
  150%;font-family:Tahoma'>�������� -Daha �nce a</span><span lang=TR
  style='line-height:150%;font-family:Tahoma'>spirasyon �yk�s� </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><span
  lang=TR style='line-height:150%;font-family:Tahoma'>-Uyan&#305;kl&#305;k
  kusuru (GKS 8 ve alt&#305;nda olmas&#305;)</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><span
  lang=TR style='line-height:150%;font-family:Tahoma'>-Kafa travmas&#305;</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><span
  lang=TR style='line-height:150%;font-family:Tahoma'>-&#304;leri dizartri/anartri</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><span
  lang=TR style='line-height:150%;font-family:Tahoma'>-Alkol komas&#305;</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><span
  lang=TR style='line-height:150%;font-family:Tahoma'>-Obezite </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='line-height:150%;font-family:Tahoma'>��������� -</span><span
  lang=TR style='line-height:150%;font-family:Tahoma'>Yutkunma bozuklu&#287;u</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='line-height:150%;font-family:Tahoma'>��������� -</span><span
  lang=TR style='line-height:150%;font-family:Tahoma'>Kusma</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='line-height:150%;font-family:Tahoma'>��������� -Bol
  sekresyonunun olmas&#305;</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='line-height:150%;font-family:Tahoma'>��������� -Nazogastrik
  sonda ile beslenme</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><span lang=TR style='line-height:150%;font-family:
  Tahoma'>�</span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>�<b>Lezyon lokalizasyonuna g�re:</b></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><span
  lang=TR style='line-height:150%;font-family:Tahoma'>-Beyinsap&#305;
  tutulmas&#305;</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><span
  lang=TR style='line-height:150%;font-family:Tahoma'>-Bilateral hemisferik
  tutulma&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><span
  lang=TR style='line-height:150%;font-family:Tahoma'>-Operk�ler sendrom </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><span
  lang=TR style='line-height:150%;font-family:Tahoma'>-Kraniyal n�ropati </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><span
  lang=TR style='line-height:150%;font-family:Tahoma'>-MG'e ba&#287;l&#305;
  olarak bulber kas tutulumu </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><span
  lang=TR style='line-height:150%;font-family:Tahoma'>-Motor n�ron
  hastal&#305;klar&#305;na ba&#287;l&#305; bulber kas tutulumu</span><span
  lang=TR style='font-size:12.0pt;line-height:150%;font-family:Tahoma'> </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><b><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></b></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=619 valign=top style='width:464.4pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><b><span lang=TR style='font-size:12.0pt;
  line-height:150%;font-family:Tahoma'>Tablo 4. Uyan&#305;kl&#305;&#287;&#305;
  bozuk olan hastalarda aspirasyon riskinin nedenleri</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
  150%;font-family:Tahoma'>�Yutkunma hareketleri azal&#305;r, a&#287;&#305;zda
  sekresyonlar birikir</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
  150%;font-family:Tahoma'>��&#287;�rme refleksi azal&#305;r</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
  150%;font-family:Tahoma'>��ks�rme refleksi azal&#305;r</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
  150%;font-family:Tahoma'>�Kafa i�i bas&#305;n� art&#305;&#351;&#305;
  sendromuna ba&#287;l&#305; olarak bulant&#305;/kusma riski artar</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
  150%;font-family:Tahoma'>�Beyinsap&#305; tutulmas&#305; s�z konusu ise
  vestib�lo-serebellar yollar&#305;n etkilenmesine ba&#287;l&#305; olarak kusma
  riski artar</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=619 valign=top style='width:464.4pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><b><span lang=TR style='font-size:12.0pt;
  line-height:150%;font-family:Tahoma'>Tablo 5. Uyan&#305;kl&#305;&#287;&#305;
  bozuk olan hastalarda aspirasyonu �nlemek a�&#305;s&#305;ndan nelere dikkat
  edilmelidir?</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
  150%;font-family:Tahoma'>�Gerekiyorsa int�be edilmelidir</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
  150%;font-family:Tahoma'>�Orofaringeal hava yolu tak&#305;l&#305;rken
  kullan&#305;lacak �airway�in boyuna dikkat edilmelidir ����</span><span
  lang=TR style='font-size:12.0pt;line-height:150%;font-family:Symbol'>[</span><span
  lang=TR style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>Tragus-a&#287;&#305;z
  komis�r� mesafesinden uzun olmamal&#305;d&#305;r</span><span lang=TR
  style='font-size:12.0pt;line-height:150%;font-family:Symbol'>]</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
  150%;font-family:Tahoma'>�Nazogastrik sonda tak&#305;l&#305;rken dikkat
  edilecekler:</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><span
  lang=TR style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>�Hastan&#305;n
  pozisyonu:</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:70.8pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><span
  lang=TR style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>-Dekubitus
  laterale </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:70.8pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><span
  lang=TR style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>-Yar&#305;
  oturur durumda</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:35.4pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><span
  lang=TR style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>�Sondan&#305;n
  yeri s�rekli kontrol edilmelidir</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
  150%;font-family:Tahoma'>�A&#287;&#305;zda biriken sekresyonlar s�rekli
  aspire edilmelidir </span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
  150%;font-family:Tahoma'>�Antiemetik ila� kullan&#305;labilir </span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
  150%;font-family:Tahoma'>�O2 sat�rasyonu izlenen hastalarda desat�rasyon
  aspirasyon epizodlar&#305; hakk&#305;nda bilgi verebilir</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=619 valign=top style='width:464.4pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoBodyText style='text-align:justify'><b><span lang=TR
  style='font-size:12.0pt;line-height:115%;font-family:Tahoma'>Tablo 6. Aspire
  etmi&#351; hastalarda ate&#351; y�kselmesi durumunda yap&#305;lmas&#305;
  gerekenler nelerdir?</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-family:Tahoma'>�Akci&#287;er grafisi</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-family:Tahoma'>�Gerekli v�cut s&#305;v&#305;s&#305; �rnekleri
  al&#305;nmas&#305;</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-family:Tahoma'>�K�lt�r sonu�lar&#305; gelene dek anaeroblar&#305;
  kapsayacak &#351;ekilde antibiyotik tedavisine ba&#351;lanmas&#305;:</span></p>
  <p class=MsoNormal style='text-align:justify;text-indent:36.0pt;line-height:
  150%'><span lang=TR style='font-family:Tahoma'>�Penisilin+sulbaktam</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-family:Tahoma'>�������� �Penisilin+klavulinik asit��������������������� </span></p>
  <p class=MsoNormal style='text-align:justify;text-indent:36.0pt;line-height:
  150%'><span lang=TR style='font-family:Tahoma'>�Klindamisin</span></p>
  <p class=MsoNormal style='text-align:justify;text-indent:36.0pt;line-height:
  150%'><span lang=TR style='font-family:Tahoma'>�Metronidazol</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='text-align:justify;text-indent:36.0pt;line-height:
150%'><span lang=TR style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%;page-break-after:avoid'><b><span lang=TR
style='font-size:14.0pt;line-height:150%;font-family:Tahoma'>Dola&#351;&#305;m Deste&#287;i</span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Hava yolu a�&#305;kl&#305;&#287;&#305; ve optimal
oksijenizasyon sa&#287;land&#305;ktan sonra m�cadele edilmesi gereken en �nemli
konular dola&#351;&#305;m ve optimal bir serebral perf�zyon bas&#305;nc&#305;n&#305;n
sa&#287;lanmas&#305;d&#305;r. Bir�ok n�rolojik olmayan acilde dola&#351;&#305;m
deste&#287;inin sa&#287;lanmas&#305;n&#305;n en vital yakla&#351;&#305;mlardan
biri oldu&#287;u bilinmektedir. Bu yakla&#351;&#305;m n�rolojik acillerde de
b�y�k �nem ta&#351;&#305;r. Bunun nedeni merkezi sinir sisteminin �zellikle
iskemik olaylarda ve intrakraniyal bas&#305;nc&#305;n artt&#305;&#287;&#305;
durumlarda iskemiye tolerans&#305;n&#305;n azalmas&#305;d&#305;r. Bu gibi
durumlarda serebral perf�zyonun optimal duruma getirilmesi ve s�rd�r�lmesi
ikincil n�rolojik hasarlar&#305;n �nlenmesi a�&#305;s&#305;ndan �nem kazan&#305;r.
Bu ama�la kardiyak output ve sistemik kan bas&#305;nc&#305; optimal d�zeyde
tutulmal&#305;d&#305;r.&nbsp;<i>N�rolojik acillerde genel olarak
hastalar&#305;n �volemik d�zeyde tutulmas&#305; en �nemli prensiptir.</i></span><span
lang=TR style='font-size:10.0pt;line-height:150%;font-family:Tahoma'> </span><span
lang=TR style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>Nab&#305;z,
kan bas&#305;nc&#305; ve doku perf�zyonunu izlemek i�in idrar
�&#305;k&#305;&#351;&#305;, kan pH's&#305; ve deri bulgular&#305; izlenmelidir
(<b>Tablo 7</b>). Damar yolu a�&#305;l&#305;p mesane sondas&#305;
yerle&#351;tirilmelidir. Damar yolu a�&#305;ld&#305;&#287;&#305;nda gerekli
biyokimyasal ara&#351;t&#305;rmalar i�in kan �rnekleri
al&#305;nmal&#305;d&#305;r (<b>Tablo 8</b>). </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=619 valign=top style='width:464.4pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><b><span lang=TR style='font-size:12.0pt;
  line-height:150%;font-family:Tahoma'>Tablo 7.&nbsp;Hemodinaminin izlenmesi
  i�in yap&#305;lacaklar nelerdir?</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:54.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-54.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Nab&#305;z takibi</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:54.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-54.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Kan bas&#305;nc&#305; takibi</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:54.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-54.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Doku perf�zyonunu izlemek i�in:</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:72.0pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><span
  lang=TR style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>-Saatlik
  idrar �&#305;k&#305;&#351;&#305; takibi</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:72.0pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><span
  lang=TR style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>-Kan
  pH�s&#305; �l��mleri</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:72.0pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><span
  lang=TR style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>-Deri
  bulgular&#305;n&#305;n izlenmesi&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:54.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-54.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Damar yolu a�&#305;lmas&#305;&nbsp;</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:54.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-54.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Mesane sondas&#305; yerle&#351;tirilmesi</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:54.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-54.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Kan �rnekleri al&#305;nmas&#305;&nbsp; </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:54.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-54.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Kardiyak monitorizasyona ba&#351;lanmas&#305;&nbsp;</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=619 valign=top style='width:464.4pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><b><span lang=TR style='font-size:12.0pt;
  line-height:150%;font-family:Tahoma'>Tablo 8. Acil durumda istenecek
  laboratuar incelemeleri nelerdir?</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><b><span lang=TR style='font-size:12.0pt;
  line-height:150%;font-family:Tahoma'>KAN:</span></b></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>&#350;eker </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Elektrolitler, �re, kreatinin </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Kalsiyum </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Karaci&#287;er fonksiyon testleri </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>PT, PTT, &#304;NR </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Tam kan say&#305;m&#305; </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Arter kan gazlar&#305; (asid-baz dengesi, anyon
  a�&#305;&#287;&#305;, laktik asid)</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><b><u><span lang=TR style='font-size:12.0pt;
  line-height:150%;font-family:Tahoma'>Gere&#287;inde:</span></u></b><span
  lang=TR style='font-size:12.0pt;line-height:150%;font-family:Tahoma'> </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Osmolarite </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Kan k�lt�rleri </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Karboksihemoglobin d�zeyi </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Spesifik serum ila� d�zeyleri (�rne&#287;in: antiepileptikler)
  </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Alkol d�zeyi </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Tiroid fonksiyon testleri, tiroid antikorlar&#305; </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Porfirin metabolizmas&#305; ara&#351;t&#305;rmas&#305; (kanda
  delta aminolev�linik asid, idrarda porfobilinojen d�zeyi)</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Antikardiyolipin antikorlar&#305;</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><b><span lang=TR style='font-size:12.0pt;
  line-height:150%;font-family:Tahoma'>&#304;DRAR:</span></b><span lang=TR
  style='font-size:12.0pt;line-height:150%;font-family:Tahoma'> </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Tam idrar tahlili </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Toksik tarama </span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><b><u><span lang=TR style='font-size:12.0pt;
  line-height:150%;font-family:Tahoma'>Gere&#287;inde:</span></u></b><span
  lang=TR style='font-size:12.0pt;line-height:150%;font-family:Tahoma'> </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>&#304;drar k�lt�r� </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>&#304;drar osmolaritesi </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
lang=TR style='font-size:12.0pt;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
lang=TR style='font-size:10.0pt;font-family:Tahoma'>�al&#305;&#351;&#305;lan
kurumda m�mk�nse hastada kardiyak monitorizasyona da
ba&#351;lanmal&#305;d&#305;r. Hastalar&#305;n erkenden kardiyak monitorizasyona
al&#305;nmas&#305; �zellikle komal&#305; hastalarda koma nedeninin
anla&#351;&#305;lmas&#305;n&#305;,� ila� intoksikasyonlar&#305;nda kardiyak ritim
komplikasyonlar&#305;n&#305;n erkenden tan&#305;nmas&#305;n&#305;, GBS'u olan
bir hastada otonomik n�ropatiye ba&#287;l&#305; kardiyak ritim
bozukluklar&#305;n&#305;n saptanmas&#305;n&#305; veya iskemik inme ile
kar&#351;&#305;m&#305;za gelen bir hastada etyolojik a�&#305;dan b�y�k
de&#287;eri olan paroksismal atrial fibrilasyonun tan&#305;nmas&#305;n&#305;
sa&#287;layabilir. </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>N�roloji aciline ba&#351;vuran ve �zellikle
a&#287;&#305;r durumda olan hastalar&#305;n bir�o&#287;u giri&#351;te
dehidratedir. Bu hastalarda serebral perf�zyonu optimumda tutman&#305;n en
�nemli yolu s&#305;v&#305; tedavisidir. Vazopress�r ila�lar&#305;n
dehidratasyon durumlar&#305;nda etkilerinin azald&#305;&#287;&#305; da g�z
�n�nde bulundurulursa tedavinin ilk standart basama&#287;&#305; s&#305;v&#305;
replasman&#305;d&#305;r. Bu tedavi yakla&#351;&#305;m&#305; �zellikle
hipotansif hastalarda �nemlidir. Akut pulmoner �dem �nemli bir potansiyel
komplikasyonsa da bir�ok hastada bu risk minimaldir. Ciddi konjestif kalp
yetmezli&#287;i oldu&#287;u bilinen ve akci&#287;er osk�ltasyonunda simetrik
ya&#351; ralleri saptanan hastalar d&#305;&#351;&#305;ndaki hastalara izotonik
NaCl eriyi&#287;inden 10-15ml/kg bolus tedavisi yap&#305;lmal&#305;d&#305;r. Bu
tedaviden sonra idame s&#305;v&#305; tedavisine ge�ilecektir.&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Hipotansif olan hastalarda dehidratasyon
d&#305;&#351;&#305;ndaki nedenler de ara&#351;t&#305;r&#305;lmal&#305;d&#305;r.
�o&#287;unlukla neden hipovolemi olsa da s&#305;v&#305; tedavisine ra&#287;men
kan bas&#305;nc&#305;nda art&#305;&#351; saptanmayan hastalarda di&#287;er
&#351;ok durumlar&#305; ara&#351;t&#305;r&#305;lmal&#305;d&#305;r. Kardiyojenik
&#351;ok, septik &#351;ok veya �st servikal spinal travmalarda oldu&#287;u gibi
n�rojenik &#351;ok di&#287;er olas&#305;l&#305;klar olarak say&#305;labilir. Bu
tip hastalarda tedaviye vazopress�r ila�lar&#305;n da eklenmesi durumun
stabilize olmas&#305;n&#305; sa&#287;layacakt&#305;r.&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>B�t�n yukar&#305;da say&#305;lan �nlemler
d&#305;&#351;&#305;nda, e&#287;er hasta anemikse eritrosit s�spansiyonu
transf�zyonu akla gelmelidir. N�rolojik acillerde optimal hematokrit de&#287;erinin
ne oldu&#287;u konusunda herhangi bir bilgi yoksa da hematokritin %30-40
d�zeylerinde tutulmas&#305; �nerilebilir. </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>N�roloji acilinde dola&#351;&#305;m deste&#287;i ve
optimum serebral perf�zyon bas&#305;nc&#305;n&#305; sa&#287;lay&#305;c&#305;
yakla&#351;&#305;mlardan bahsederken en s&#305;k rastlanan sorunlardan biri
olan hipertansiyona yakla&#351;&#305;m prensiplerinden de bahsetmek gerekir.
N�roloji acil polikliniklerinde en s&#305;k tedavi edilen hasta pop�lasyonu
iskemik veya hemorajik inmeli hastalard&#305;r. �Bu hastalar&#305;n
�o&#287;unlu&#287;u kar&#351;&#305;m&#305;za hipertansiyonla
�&#305;kmaktad&#305;r. &#304;ntraserebral hematomlar d&#305;&#351;&#305;nda kafa
i�i bas&#305;n� art&#305;&#351;&#305; sendromuna (K&#304;BAS) yol a�an akut
kitle sendromu olan hastalar ile GBS'e ba&#287;l&#305; olarak otonomik tutulumu
olan hastalarda da hipertansiyon izlenmektedir. N�roloji acilinde hipertansiyon
a�&#305;s&#305;ndan aciller (miyokard infarkt�s�, akut pulmoner �dem, aort
diseksiyonu, hipertansif ensefalopati vs) gibi kesin tedavi indikasyonlar&#305;
olmad&#305;k�a, hasta stabilize olana, kesin etyolojik tan&#305; ve spesifik
tedavi giri&#351;imleri uygulanana dek y�ksek kan bas&#305;nc&#305;
de&#287;erlerine m�dahaleden ka�&#305;n&#305;lmal&#305;d&#305;r.</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
lang=TR style='font-size:10.0pt;font-family:Tahoma'>Akut iskemik inmede ciddi
hipertansiyon (sistolik&nbsp;</span><span lang=TR style='font-size:10.0pt;
font-family:Symbol'>&gt;</span><span lang=TR style='font-size:10.0pt;
font-family:Tahoma'>220-230, diastolik&nbsp;</span><span lang=TR
style='font-size:10.0pt;font-family:Symbol'>&gt;</span><span lang=TR
style='font-size:10.0pt;font-family:Tahoma'>130-</span><span
 lang=TR style='font-size:10.0pt;font-family:Tahoma'>140 mm</span><span
lang=TR style='font-size:10.0pt;font-family:Tahoma'> Hg), hipertansif
ensefalopati,&nbsp;</span><span lang=TR style='font-size:10.0pt;font-family:
Tahoma'>mikroskopik hemat�ri ve protein�ri ile karakterize belirgin b�brek
yetmezli&#287;i, papilla �demi, retinal hemoraji ve eksudalarla karakterize
ciddi hipertansif retinopati bulgular&#305;, konjestif</span><span lang=TR
style='font-size:10.0pt;font-family:Tahoma'> kalp yetmezli&#287;i, miyokard
iskemisi ve aort diseksiyonu gibi mutlak tedavi gerektiren, hipertansiyon i�in acil
durumlar d&#305;&#351;&#305;nda inmenin akut d�neminde en az&#305;ndan ilk 72
saat, e&#287;er m�mk�nse de ilk bir-iki hafta s�resince hipertansiyona m�dahale
etmemek temkinli bir yakla&#351;&#305;md&#305;r. Hiperakut d�nemde
antihipertansif tedavi uygulanacaksa etkisi �nceden tahmin edilemeyecek
kontrols�z hipotansiyona yol a�abilen sublingual nifedipinden ka�&#305;nmak
gerekir. &#304;lk tercih, etkisi h&#305;zl&#305; ba&#351;layan ve
kesildi&#287;inde �abuk sonlanan paranteral esmolol, nitrogliserin veya
nitroprusid olabilir. Saatler i�inde etkili olacak &#351;ekilde oral kaptopril
veya oral nifedipin de kullan&#305;labilir. Daha h&#305;zl&#305; etki
hedefleniyorsa kaptopril �i&#287;netilebilir. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
lang=TR style='font-size:10.0pt;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
lang=TR style='font-size:10.0pt;font-family:Tahoma'>Hemorajik inmeli hastalarda
�nerilebilecek en agresif yakla&#351;&#305;m uyan&#305;k hastada sistolik kan
bas&#305;nc&#305;n&#305;n 180 mmHg'yi, diastolik kan bas&#305;nc&#305;n&#305;n
da 105 mmHg'yi a&#351;t&#305;&#287;&#305; durumlarda bilin� takibi
yap&#305;larak tedaviye ba&#351;lamakt&#305;r. Bilinci kapal&#305; hastalarda
ideal &#351;artlarda intrakraniyal bas&#305;n� monitorizasyonu yaparak tedaviyi
d�zenlemek gerekir. Bunun yap&#305;lamad&#305;&#287;&#305; durumlarda daha
konservatif davranmak do&#287;ru olacakt&#305;r. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
lang=TR style='font-size:10.0pt;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
lang=TR style='font-size:10.0pt;font-family:Tahoma'>Akut iskemik inme ile gelen
bir hastada hipergliseminin tedavisi de ayr&#305; bir tart&#305;&#351;ma
konusudur. Paranteral ins�lin tedavisi ile normogliseminin
sa&#287;lanmas&#305;n&#305;n prognoz �zerine etkisi ilk olarak cerrahi
yo&#287;un bak&#305;m �nitesinde (CYB�) izlenen hastalarda g�sterilmi&#351;tir.
CYBܒde n�rolojik hastal&#305;k nedeni ile yatan bir alt grupta da ayn&#305;
etki g�zlenmi&#351;tir. Ancak dahili yo&#287;un bak&#305;m �nitelerinde bu etki
do&#287;rulanmam&#305;&#351;, hatta hipoglisemi epizodlar&#305;n&#305;n
mortalite ile ili&#351;kili olabilece&#287;i g�r�lm�&#351;t�r. N�rolojik acil
tablolarda bu tedavinin spesifik etkisi bilinmemektedir. Akut iskemik inmede bu
konuyla ilgili s�ren �al&#305;&#351;malar mevcuttur. Akut revask�larizasyon
tedavisi uygulanm&#305;&#351; hastalarda hipergliseminin hemorajik
transformasyon riskini artt&#305;rd&#305;&#287;&#305; g�z �n�nde bulundurulursa,
kan &#351;ekeri &gt;180 mg/dl olan akut iskemik inmeli hastalarda
�al&#305;&#351;&#305;lan kurumda saatlik kan &#351;ekeri takibi
yap&#305;labiliyorsa erken d�nemde paranteral ins�lin tedavisi
ba&#351;lanmas&#305; �nerilebilir.� �����</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
lang=TR style='font-size:10.0pt;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><b><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%;page-break-after:avoid'><b><span lang=TR
style='font-size:14.0pt;line-height:150%;font-family:Tahoma'>Defisitin De&#287;erlendirilmesi
</span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>A&#287;&#305;r n�rolojik hastada ABC
yakla&#351;&#305;m&#305; uygulamalar&#305; sonucunda solunum ve hemodinamik
a�&#305;dan stabilizasyon sa&#287;land&#305;ktan sonra n�rolojik
de&#287;erlendirmeye ge�ilecektir. Bu de&#287;erlendirmenin amac&#305;: </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
font-family:Tahoma'>N�rolojik fonksiyonun d�zeyini belirlemek&nbsp;, </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
font-family:Tahoma'>N�rolojik prognozu k�t�le&#351;tirme potansiyeli olan
durumlar&#305;n acil tedavilerini ba&#351;latmak, </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
font-family:Tahoma'>N�rolojik hastal&#305;&#287;&#305;n tan&#305;s&#305;na
ula&#351;mak, </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
font-family:Tahoma'>N�rolojik fonksiyonun seyrini izlemeye
ba&#351;lamakt&#305;r. </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Bu basamakta, bu b�l�m�n ba&#351;&#305;nda genel
olarak belirtti&#287;imiz gibi, n�rolojik de&#287;erlendirme k&#305;sa fakat �z
olacakt&#305;r. Bu basamak t�m anormal patolojik reflekslerin
arand&#305;&#287;&#305; veya ileri d�zeyde kognitif de&#287;erlendirmenin
yap&#305;laca&#287;&#305;, saatler s�rebilecek bir basamak de&#287;ildir. Muayene
m�mk�n oldu&#287;unca standart ve h&#305;zl&#305; bir bi�imde
yap&#305;lmal&#305;d&#305;r. En �ok 15 dakika i�erisinde klini&#287;i ve
tedaviyi y�nlendirecek bilgiler toplanmal&#305;d&#305;r.
�al&#305;&#351;&#305;lan kurumda bu basamakta m�mk�nse n�rolojik fonksiyon
d�zeyini belirlemeye y�nelik GKS<i> </i>gibi standart de&#287;erlendirme
skalalar&#305;n&#305;n kullan&#305;lmas&#305; �zendirilmelidir. Bu basamakta
ayr&#305;ca tam bir sistemik muayene yap&#305;lacak, aile bireyleri veya
hastay&#305; acile getiren ki&#351;ilerle de konu&#351;ulup bilgi
toplanacakt&#305;r. Hasta art&#305;k solunum ve hemodinamik a�&#305;dan
stabilize oldu&#287;undan tan&#305; ve tedavi amac&#305;yla ba&#351;ka bir
birime transfer edilebilecektir. Tan&#305;ya g�t�r�c� n�rolojik g�r�nt�leme
incelemeleri, gerekiyorsa EEG ve BOS incelemeleri bu d�nemde ger�ekle&#351;tirilecektir.
Yine bu d�nemde ba&#351;lang&#305;�ta istenmi&#351; biyokimyasal incelemelerin
sonu�lar&#305; al&#305;n&#305;p de&#287;erlendirilecektir. ABC
yakla&#351;&#305;m&#305;nda<i> </i>ama� hayat&#305; tehlikeye sokan
durumlar&#305; tedavi etmekse, bu basamakta da en �nemli ama�, tan&#305;
koyman&#305;n yan&#305; s&#305;ra n�rolojik prognozu tehlikeye sokan
durumlar&#305;n medikal ve cerrahi tedavilerine ba&#351;lamakt&#305;r. </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span lang=TR style='font-size:14.0pt;
font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span lang=TR style='font-size:14.0pt;
font-family:Tahoma'>AC&#304;L N�ROLOJ&#304;K OLAYLARDA TANIYA
G&#304;D&#304;&#350; VE TANI �NCEL&#304;KLER&#304; </span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal;page-break-after:avoid'><b><span lang=TR
style='font-size:12.0pt;font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal;page-break-after:avoid'><b><span lang=TR
style='font-size:14.0pt;font-family:Tahoma'>Genel Bak&#305;&#351;&nbsp; </span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Sinir sisteminde hasarlanma iki bi�imde olur: </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><b><i><span lang=TR style='font-size:12.0pt;
line-height:150%;font-family:Tahoma'>1. Yap&#305;sal hasarlar (str�kt�rel
hasarlar, fokal lezyonlar) </span></i></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Bu durumda sinir sisteminin belli bir b�lgesinde bir
lezyon olu&#351;mu&#351;tur. Lezyonun olu&#351;tu&#287;u b�lgenin
fonksiyonlar&#305; se�ici olarak bozuldu&#287;undan, hastada o b�lgede lezyon
varl&#305;&#287;&#305;n&#305; g�steren fokal n�rolojik defisit ortaya
�&#305;kar. &#304;nfarkt, hematom, t�m�r �rnek olarak verilebilir. Bu lezyon
�ok b�y�kse ve kitle etkisine yol a�m&#305;&#351;sa hastada uyan&#305;kl&#305;k
kusuru geli&#351;ebilir. </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><b><i><span lang=TR style='font-size:12.0pt;
line-height:150%;font-family:Tahoma'>&nbsp;</span></i></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><b><i><span lang=TR style='font-size:12.0pt;
line-height:150%;font-family:Tahoma'>2. Yap&#305;sal olmayan hasarlar
(non-str�kt�rel hasarlar, yayg&#305;n bozukluklar)</span></i></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Sinir sistemi h�crelerinde yayg&#305;n olarak
metabolizma bozukluklar&#305;, ileti&#351;im bozukluklar&#305; gibi, daha �ok
molek�ler d�zeydeki bozukluklard&#305;r. Bu durumda sinir sisteminin belli bir
b�lgesi se�ici olarak tutulmad&#305;&#287;&#305;ndan fokal n�rolojik defisit
mutad de&#287;ildir. Buna kar&#351;&#305;l&#305;k sinir sistemi yayg&#305;n
olarak tutuldu&#287;undan, de&#287;i&#351;ik d�zeylerdeki uyan&#305;kl&#305;k
kusuru tablonun ana unsurudur. Uyan&#305;kl&#305;k kusurunun derinli&#287;i
�o&#287;unlukla klinik tablonun a&#287;&#305;rl&#305;&#287;&#305; ile
orant&#305;l&#305;d&#305;r. Metabolik komalar, intoksikasyonlar, hipoksik ensefalopatiler
ve hipertansif ensefalopatiler bu gruba �rnek olu&#351;tururlar.</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:
150%;font-family:Tahoma'>Uyan&#305;kl&#305;k kusuru ile gelen bir hastada
epilepsi �yk�s� olsun olmas&#305;n epileptik n�bet
olas&#305;l&#305;&#287;&#305; akla gelmelidir. Status epileptikus (SE) n�roloji
acil polikliniklerinde s&#305;k kar&#351;&#305;la&#351;&#305;lan ve kolay
tan&#305;nan bir klinik durumken, nonkonv�lzif status epileptikus (NKSE)
tan&#305;s&#305; ge� ve g�� konan bir tablodur. Hastan&#305;n klinik olarak
n�beti bitmi&#351; ve g�zden ka�m&#305;&#351; olabilir. Bu nedenle konf�zyonel
tabloda postiktal konf�zyon ve uzayan 30 dakikay&#305; a&#351;an bir postiktal
konf�zyon tablosunda da NKSE mutlaka akla gelmelidir. Konf�zyondan komaya varan
uyan&#305;kl&#305;k kusurunun yan&#305; s&#305;ra n</span><span lang=TR
style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>ormal bir insanda
her zamankinden farkl&#305;l&#305;k g�steren bir davran&#305;&#351;
de&#287;i&#351;ikli&#287;ine e&#351;lik eden EEG�de devaml&#305; n�bet
aktivitesi bu tan&#305;y&#305; koydurur. </span><span lang=TR style='font-size:
10.0pt;line-height:150%;font-family:Tahoma'>Tan&#305;n&#305;n konulabilmesi
i�in mutlaka akla gelmesi, ku&#351;kulan&#305;lan durumlarda acil EEG
incelemesinin yap&#305;lmas&#305; gerekir. Acil EEG
yap&#305;lamad&#305;&#287;&#305; durumlarda damar i�i benzodiazepin (diazepam)
ve hatta gere&#287;inde difenilhidantoin uygulamas&#305; ile hastan&#305;n
klinik tablosunun d�zeldi&#287;i olgular bildirilmi&#351; ve tedaviden tan&#305;ya
gidilmesi �nerilmi&#351;tir. �</span><span lang=TR style='font-size:10.0pt;
line-height:150%;font-family:Tahoma'>Hastalarda otomatizma, g�z ve g�z
kapaklar&#305;ndaki ritmik hareketlere de dikkat edilmelidir.� </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>EEG, NKSE tablosunda tan&#305; koydurucu tek
laboratuvar incelemesi olmas&#305;n&#305;n yan&#305; s&#305;ra periyodik lateralizan
epileptiform de&#351;arj&#305;n (PLED) g�r�lmesi ile herpes simpleks
ensefaliti, trifazik dalgalar&#305;n g�r�lmesi ile de hepatik veya �remik ensefalopati
tan&#305;s&#305; koymam&#305;z&#305; destekler. &#304;leti&#351;im kurulamayan
bir hastada normal bir EEG incelemesinin olmas&#305; da baz&#305; konversiyon
bozukluklar&#305;n&#305;n tan&#305;s&#305;nda yard&#305;mc&#305;
olacakt&#305;r.�� �</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%;page-break-after:avoid'><b><i><span lang=TR
style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>&nbsp;</span></i></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%;page-break-after:avoid'><b><span lang=TR
style='font-size:14.0pt;line-height:150%;font-family:Tahoma'>Tan&#305;
Prensipleri </span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Hasta acil poliklini&#287;e girdi&#287;i andan
itibaren, g�zlem, anamnez, n�rolojik muayene ve en sonunda da �zg�n
incelemelerle etkin bir bi�imde de&#287;erlendirilmelidir. H&#305;zl&#305; ve
normal ko&#351;ullara g�re �ok daha s&#305;n&#305;rl&#305; ancak dikkatli ve
gerekli �l��de yap&#305;labilen bu i&#351;lemlerden maksimum bilgi elde
edilmeye �al&#305;&#351;&#305;lmal&#305;d&#305;r. Vital fonksiyonlar&#305; ilk
andan itibaren emniyete al&#305;nan hastada bu a&#351;amalar&#305;n her
birinde, en s&#305;k rastlanan tan&#305; olas&#305;l&#305;klar&#305; ard&#305;
s&#305;ra d�&#351;�n�lmelidir. En s&#305;k g�r�len olas&#305;l&#305;klar&#305;n
�ncelikle d�&#351;�n�lmesi, basit tetkiklerin �nce yap&#305;lmas&#305; bir�ok
kez olduk�a yol g�sterici ve yard&#305;mc&#305; olmaktad&#305;r. O s&#305;rada
bulunulandan bir sonraki a&#351;aman&#305;n, o anda d�&#351;�n�len
tan&#305;y&#305; desteklemesi veya d&#305;&#351;lamas&#305; gerekmektedir. Bu,
tan&#305;n&#305;n daha do&#287;ruya yakla&#351;mas&#305;na katk&#305;da
bulunacakt&#305;r. </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><b><i><span lang=TR style='font-size:12.0pt;
line-height:150%;font-family:Tahoma'>Hastan&#305;n acil poliklini&#287;e
ba&#351;vurmas&#305;na neden olan klinik tablo nedir?&nbsp;Klinik tablo
nas&#305;l ortaya �&#305;km&#305;&#351;t&#305;r?</span></i></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%;page-break-after:avoid'><i><span lang=TR
style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>G�zlem&nbsp;</span></i></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Hastalar&#305;n acil n�roloji poliklini&#287;ine
girerken sunduklar&#305; g�r�nt�, olas&#305; n�rolojik tablo ve hasarlanan
sinir sistemi yap&#305;lar&#305;n&#305; bazen ele verebilir <b>(Tablo 9)</b>.</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=654
 style='width:490.5pt;margin-left:3.5pt;border-collapse:collapse;border:none'>
 <tr style='page-break-inside:avoid'>
  <td width=654 colspan=3 valign=top style='width:490.5pt;border:none;
  border-bottom:solid windowtext 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>Tablo 9.
  Acil poliklinikte g�zlem</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=406 valign=top style='width:304.65pt;border:solid windowtext 1.0pt;
  border-top:none;background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>BA&#350;VURU
  NEDEN&#304;</span></b></p>
  </td>
  <td width=105 valign=top style='width:79.0pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>UYUKLAMA</span></b></p>
  </td>
  <td width=142 valign=top style='width:106.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>FOKAL
  N�ROLOJ&#304;K DEF&#304;S&#304;T</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=406 valign=top style='width:304.65pt;border:solid windowtext 1.0pt;
  border-top:none;background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>HASTA UYANIK.
  GENELL&#304;KLE KEND&#304;S&#304; GEL&#304;R. G�ZLEND&#304;&#286;&#304;NDE
  D&#304;KKAT&#304; �EKEN B&#304;R �ZELL&#304;K YOK: Gelip ge�ici epizodik
  tablolar (epileptik n�bet, ge�ici iskemik atak, migren ata&#287;&#305;,
  psikiyatrik hastal&#305;klar)</span></p>
  </td>
  <td width=105 valign=top style='width:79.0pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>YOK</span></p>
  </td>
  <td width=142 valign=top style='width:106.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>YOK</span></p>
  </td>
 </tr>
 <tr>
  <td width=406 valign=top style='width:304.65pt;border:solid windowtext 1.0pt;
  border-top:none;background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>HASTA UYANIK.
  KEND&#304;S&#304; GEL&#304;R VEYA BA&#350;KASININ YARDIMI &#304;LE
  GET&#304;R&#304;L&#304;R. FONKS&#304;YON BOZUKLU&#286;UNU YANSITAN
  N�ROLOJ&#304;K DEF&#304;S&#304;T D&#304;KKAT&#304; �EKEB&#304;L&#304;R.</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>(Str�kt�rel
  bozukluk yapan herhangi bir lezyon)</span></p>
  </td>
  <td width=105 valign=top style='width:79.0pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>YOK</span></p>
  </td>
  <td width=142 valign=top style='width:106.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>VAR</span></p>
  </td>
 </tr>
 <tr>
  <td width=406 valign=top style='width:304.65pt;border:solid windowtext 1.0pt;
  border-top:none;background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>HASTA
  GET&#304;R&#304;L&#304;R (GENELL&#304;KLE AMBULANS &#304;LE).
  KEND&#304;S&#304; UYUKLAMAKTADIR, YANINDAK&#304;LER TELA&#350;LIDIR. HASTADA
  UYANIKLIK KUSURU DI&#350;INDA, FONKS&#304;YON BOZUKLU&#286;UNU YANSITAN FOKAL
  N�ROLOJ&#304;K DEF&#304;S&#304;T G�ZLENEB&#304;L&#304;R. LEZYON BEY&#304;N
  VEYA BEY&#304;NSAPINI &#304;LG&#304;LEND&#304;RMEKTED&#304;R.</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:normal'><span
  lang=TR style='font-size:10.0pt;font-family:Tahoma'>Str�kt�rel bozukluk yapan
  herhangi bir lezyon----Eski hemiparezi d&#305;&#351;lanmal&#305;</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:normal'><span
  lang=TR style='font-size:10.0pt;font-family:Tahoma'>Epileptik n�bet,
  postiktal konf�zyon ve Todd paralizisi</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:normal'><span
  lang=TR style='font-size:10.0pt;font-family:Tahoma'>Str�kt�rel bozukluk
  epileptik n�betle prezante olmu&#351; olabilir</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:normal'><span
  lang=TR style='font-size:10.0pt;font-family:Tahoma'>Fokal n�rolojik defisitin
  e&#351;lik etti&#287;i uyan&#305;kl&#305;k kusurunda hiponatremi, hipoglisemi
  de d&#305;&#351;lanmal&#305;</span></p>
  </td>
  <td width=105 valign=top style='width:79.0pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>VAR</span></p>
  </td>
  <td width=142 valign=top style='width:106.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>VAR</span></p>
  </td>
 </tr>
 <tr>
  <td width=406 valign=top style='width:304.65pt;border:solid windowtext 1.0pt;
  border-top:none;background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>HASTA
  GET&#304;R&#304;L&#304;R (GENELL&#304;KLE AMBULANS &#304;LE).
  KEND&#304;S&#304; UYUKLAMAKTADIR, YANINDAK&#304;LER TELA&#350;LIDIR. HASTADA
  UYANIKLIK KUSURU DI&#350;INDA, FONKS&#304;YON BOZUKLU&#286;U YANSITAN FOKAL
  N�ROLOJ&#304;K B&#304;R DEF&#304;S&#304;T GENELL&#304;KLE D&#304;KKAT&#304;
  �EKMEZ. Str�kt�rel olmayan lezyonlar---- Metabolik, toksik veya infektif
  olaylar. Postiktal konf�zyon ve/veya uzayan bir postiktal konf�zyon
  tablosunda NKSE akla gelmelidir</span></p>
  </td>
  <td width=105 valign=top style='width:79.0pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>VAR</span></p>
  </td>
  <td width=142 valign=top style='width:106.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>YOK</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='text-align:justify'><span lang=TR style='font-family:
Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%;page-break-after:avoid'><i><span lang=TR
style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>Anamnez </span></i></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Acil n�roloji poliklini&#287;ine ba&#351;vuran hastada
anamnez al&#305;rken sorulacak stratejik iki sorudan ilki &quot;<i>ne
oldu&#287;u</i>&quot;, ikincisi ise klinik tablonun <i>&quot;nas&#305;l ortaya
�&#305;kt&#305;&#287;&#305;d&#305;r&quot;</i>. Ne oldu sorusunun
yan&#305;t&#305; elbette �ok �nemlidir ancak �nas&#305;l� sorusunun
yan&#305;t&#305; ay&#305;r&#305;c&#305; tan&#305;
olas&#305;l&#305;klar&#305;n&#305; daraltacakt&#305;r. Geli&#351;me bi�imlerine
g�re baz&#305; klinik tablolar a&#351;a&#287;&#305;daki <b>Tablo 10</b>�da
g�sterilmi&#351;tir.</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=643
 style='width:17.0cm;margin-left:3.5pt;border-collapse:collapse;border:none'>
 <tr style='page-break-inside:avoid'>
  <td width=643 colspan=2 valign=top style='width:17.0cm;border:none;
  border-bottom:solid windowtext 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>&nbsp; <b>Tablo
  10. Geli&#351;imlerine g�re acil n�rolojik olaylar</b> </span></p>
  </td>
 </tr>
 <tr>
  <td width=215 valign=top style='width:161.0pt;border:solid windowtext 1.0pt;
  border-top:none;background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>KL&#304;N&#304;K
  TABLONUN GEL&#304;&#350;ME B&#304;�&#304;M&#304;</span></b></p>
  </td>
  <td width=428 valign=top style='width:320.95pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>�RNEKLER</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=215 valign=top style='width:161.0pt;border:solid windowtext 1.0pt;
  border-top:none;background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <h1 style='text-align:justify'><span lang=TR style='font-size:10.0pt;
  font-family:Tahoma'>AKUT</span></h1>
  </td>
  <td width=428 valign=top style='width:320.95pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-left:36.0pt;margin-bottom:
  .0001pt;text-align:justify;text-indent:-36.0pt;line-height:normal'><span
  lang=TR style='font-size:10.0pt;font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>Serebrovask�ler
  hastal&#305;klar</span><span lang=TR style='font-family:Tahoma'> </span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-left:106.8pt;margin-bottom:
  .0001pt;text-align:justify;text-indent:-106.8pt;line-height:normal'><span
  lang=TR style='font-size:10.0pt;font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>-&#304;skemik
  </span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-left:106.8pt;margin-bottom:
  .0001pt;text-align:justify;text-indent:-106.8pt;line-height:normal'><span
  lang=TR style='font-size:10.0pt;font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>-Hemorajik</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-left:36.0pt;margin-bottom:
  .0001pt;text-align:justify;text-indent:-36.0pt;line-height:normal'><span
  lang=TR style='font-size:10.0pt;font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>Travma</span><span
  lang=TR style='font-family:Tahoma'> </span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-left:36.0pt;margin-bottom:
  .0001pt;text-align:justify;text-indent:-36.0pt;line-height:normal'><span
  lang=TR style='font-size:10.0pt;font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>Toksik
  komalar</span><span lang=TR style='font-family:Tahoma'> </span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-left:36.0pt;margin-bottom:
  .0001pt;text-align:justify;text-indent:-36.0pt;line-height:normal'><span
  lang=TR style='font-size:10.0pt;font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>Epileptik
  n�bet</span><span lang=TR style='font-family:Tahoma'> </span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-left:36.0pt;margin-bottom:
  .0001pt;text-align:justify;text-indent:-36.0pt;line-height:normal'><span
  lang=TR style='font-size:10.0pt;font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>Periyodik
  paraliziler</span><span lang=TR style='font-family:Tahoma'> </span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-left:36.0pt;margin-bottom:
  .0001pt;text-align:justify;text-indent:-36.0pt;line-height:normal'><span
  lang=TR style='font-size:10.0pt;font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>Rabdomiyoliz</span><span
  lang=TR style='font-family:Tahoma'> </span></p>
  </td>
 </tr>
 <tr>
  <td width=215 valign=top style='width:161.0pt;border:solid windowtext 1.0pt;
  border-top:none;background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <h1 style='text-align:justify'><span lang=TR style='font-size:10.0pt;
  font-family:Tahoma'>SUBAKUT</span></h1>
  </td>
  <td width=428 valign=top style='width:320.95pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:normal'><span lang=TR style='font-size:10.0pt;font-family:Symbol'>�<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>&#304;nfeksiyon</span><span
  lang=TR style='font-family:Tahoma'> </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:72.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-72.0pt;
  line-height:normal'><span lang=TR style='font-size:10.0pt;font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>Menenjit</span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:72.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-72.0pt;
  line-height:normal'><span lang=TR style='font-size:10.0pt;font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>Ensefalit</span><span
  lang=TR style='font-family:Tahoma'> </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:72.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-72.0pt;
  line-height:normal'><span lang=TR style='font-size:10.0pt;font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>Abse</span><span
  lang=TR style='font-family:Tahoma'> </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:normal'><span lang=TR style='font-size:10.0pt;font-family:Symbol'>�<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>Metabolik
  komalar</span><span lang=TR style='font-family:Tahoma'> </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:normal'><span lang=TR style='font-size:10.0pt;font-family:Symbol'>�<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>Demiyelinizan
  hastal&#305;klar</span><span lang=TR style='font-family:Tahoma'> </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:72.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-72.0pt;
  line-height:normal'><span lang=TR style='font-size:10.0pt;font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>Akut
  demiyelinizan ensefalomiyelit (ADEM)</span><span lang=TR style='font-family:
  Tahoma'> </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:72.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-72.0pt;
  line-height:normal'><span lang=TR style='font-size:10.0pt;font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>Multipl
  Skleroz ata&#287;&#305;</span><span lang=TR style='font-family:Tahoma'> </span></p>
  <p class=MsoFooter style='margin-left:36.0pt;text-align:justify;text-indent:
  -36.0pt'><span lang=TR style='font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Hipertansif
  ensefalopati </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:normal'><span lang=TR style='font-size:10.0pt;font-family:Symbol'>�<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>Di&#287;er
  inflamatuar sinir sistemi hastal&#305;klar&#305; </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:72.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-72.0pt;
  line-height:normal'><span lang=TR style='font-size:10.0pt;font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>Vask�litler
  </span></p>
  <p class=MsoFooter style='margin-left:72.0pt;text-align:justify;text-indent:
  -72.0pt'><span lang=TR style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>N�ro-Beh�et </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:normal'><span lang=TR style='font-size:10.0pt;font-family:Symbol'>�<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>MG </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:normal'><span lang=TR style='font-size:10.0pt;font-family:Symbol'>�<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>GBS </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:normal'><span lang=TR style='font-size:10.0pt;font-family:Symbol'>�<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>Polimiyozit-dermatomiyozit</span></p>
  </td>
 </tr>
 <tr>
  <td width=215 valign=top style='width:161.0pt;border:solid windowtext 1.0pt;
  border-top:none;background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <h1 style='text-align:justify'><span lang=TR style='font-size:10.0pt;
  font-family:Tahoma'>KRON&#304;K</span></h1>
  </td>
  <td width=428 valign=top style='width:320.95pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:normal'><span lang=TR style='font-size:10.0pt;font-family:Symbol'>�<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>Beyin
  t�m�rleri</span><span lang=TR style='font-family:Tahoma'> </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:normal'><span lang=TR style='font-size:10.0pt;font-family:Symbol'>�<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>K&#304;BAS</span><span
  lang=TR style='font-family:Tahoma'> </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:normal'><span lang=TR style='font-size:10.0pt;font-family:Symbol'>�<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:10.0pt;font-family:Tahoma'>Kronik
  subdural hematom</span><span lang=TR style='font-family:Tahoma'> </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><b><u><span lang=TR style='font-size:12.0pt;
line-height:150%;font-family:Tahoma'><span style='text-decoration:none'>&nbsp;</span></span></u></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><b><i><span lang=TR style='font-size:12.0pt;
line-height:150%;font-family:Tahoma'>Lezyon sinir sisteminin neresini
etkilemi&#351;tir? </span></i></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><i><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>N�rolojik Muayene</span></i><span lang=TR
style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>&nbsp; </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Acil poliklinikteki k&#305;sa n�rolojik muayenenin
mutlaka olmas&#305; gereken bile&#351;enleri (daha sonra etrafl&#305;ca
tekrarlanmak �zere) <b>Tablo</b> <b>11</b>�de belirtilmi&#351;tir. Muayenenin
di&#287;er bile&#351;enleri yeri geldik�e ve gerektik�e mutlaka bu &#351;emaya
eklenmelidir.</span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma'>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=619 valign=top style='width:464.4pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <h1 style='text-align:justify'><span lang=TR style='font-size:12.0pt;
  font-family:Tahoma'>Tablo 11. Acilde n�rolojik muayene</span></h1>
  </td>
 </tr>
 <tr>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Hastan&#305;n
  uyan&#305;kl&#305;k d�zeyi </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Fundoskopi </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Ekstraok�ler kaslar </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Refleks g�z
  hareketleri </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Nistagmus </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Pupilla b�y�kl�&#287;�
  ve &#305;&#351;&#305;k refleksi </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Mimik kaslar&#305; </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Meningeal iritasyon
  bulgular&#305; </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Parezi testleri
  (uyan&#305;k ve uyuklayan hastada farkl&#305;) </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Derin tendon
  refleksleri (DTR) </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-family:Tahoma'>Patolojik refleksler </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><b><i><span lang=TR style='font-size:12.0pt;
line-height:150%;font-family:Tahoma'>En olas&#305; etyolojik tan&#305; nedir? </span></i></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>N�rolojide acil hekimli&#287;in en �nemli amac&#305;
&quot;ne oldu&quot; , &quot;nas&#305;l oldu&quot; ve �neresi� sorular&#305;na
cevap vermenin yan&#305; s&#305;ra h&#305;zl&#305;ca ilerleyen ve hayat&#305;
tehdit etme potansiyeli olan hastal&#305;k kar&#351;&#305;s&#305;nda etkin bir
de&#287;erlendirme ile h&#305;zl&#305; tan&#305; ve tedavi giri&#351;imi
uygulayabilmektir. Bu amaca ula&#351;mada en �nemli basamak b�yle bir
hastal&#305;k s�reci ile kar&#351;&#305;m&#305;za �&#305;kan hastay&#305;
tan&#305;yabilmek, yani <i>&quot;hangisi&quot;</i> sorusuna cevap
verebilmektir. Bu tip hastalar&#305; tan&#305;man&#305;n en �nemli ko&#351;ulu
sistematik ve algoritmik bir yakla&#351;&#305;m uygulama becerisidir.&nbsp; </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Hekimin hastas&#305; ile ilk
kar&#351;&#305;la&#351;t&#305;&#287;&#305;nda hangi hastan&#305;n, ne derecede
acil bir n�rolojik durumla kar&#351;&#305; kar&#351;&#305;ya oldu&#287;una
karar vermesi �o&#287;unlukla m�mk�n de&#287;ildir. Hekimin bu karar&#305;
verebilmesi ancak hastas&#305;ndan veya hasta yak&#305;nlar&#305;ndan
ald&#305;&#287;&#305; anamnez, yapt&#305;&#287;&#305; do&#287;ruya en
yak&#305;n sistemik ve n�rolojik muayene ile n�rolojik sendrom kategorilerini
belirleyebilme yetene&#287;ine ba&#287;l&#305;d&#305;r. <b>Tablo</b> <b>12</b>�de
n�rolojik sendrom kategorilerinden en �nemlileri belirtilmi&#351;tir. Acile gelen
hasta m�mk�n oldu&#287;unca bu sendrom kategorilerinden birine
sokulabilmelidir. N�rolojik sendrom kategorisini belirleyebilmek bu kategori
i�inde yer alan ve tan&#305;/tedavi a�&#305;s&#305;ndan �nemli
hastal&#305;klar&#305;n tan&#305;nmas&#305;n&#305;
kolayla&#351;t&#305;racakt&#305;r. </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp; </span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='margin-left:5.4pt;border-collapse:collapse;border:none'>
 <tr>
  <td width=576 valign=top style='width:432.35pt;border:none;border-bottom:
  solid windowtext 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
  justify;line-height:150%'><b><span lang=TR style='font-size:12.0pt;
  line-height:150%;font-family:Tahoma'>Tablo 12. N�rolojik acilde baz&#305;
  sendrom kategorileri</span></b><span lang=TR style='font-size:12.0pt;
  line-height:150%;font-family:Tahoma'> </span></p>
  </td>
 </tr>
 <tr>
  <td width=576 valign=top style='width:432.35pt;border:solid windowtext 1.0pt;
  border-top:none;background:white;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Bilin� bozukluklar&#305; </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Epileptik n�bet </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Status Epileptikus </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Febril n�rolojik sendrom </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Akut g�rme kayb&#305; </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Akut diplopi </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Akut vertigo </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Akut kas zaaf&#305; </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Akut ba&#351;a&#287;r&#305;s&#305; </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Akut med�ller sendrom </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Akut y�r�y�&#351; ve denge bozuklu&#287;u </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Akut hareket bozukluklar&#305; </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Akut a&#287;r&#305; sendromu </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Akut demansiyel sendrom </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Akut organik davran&#305;&#351; bozuklu&#287;u </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Akut bellek bozuklu&#287;u </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>K&#304;BAS </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Akut multifokal n�rolojik disfonksiyon </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
  line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
  font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
  font-family:Tahoma'>Ge�ici n�rolojik defisit </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span lang=TR style='font-size:12.0pt;font-family:
Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><b><i><span lang=TR style='font-size:12.0pt;
line-height:150%;font-family:Tahoma'>Lezyonun tipi nedir?</span></i></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%;page-break-after:avoid'><i><span lang=TR
style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>G�r�nt�leme ve
yard&#305;mc&#305; incelemeler</span></i></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>G�zlem, anamnez ve n�rolojik muayene sonucunda elde
edilen bilgilerin do&#287;rulanmas&#305; amac&#305;yla yap&#305;lacak
yard&#305;mc&#305; incelemeler a�&#305;s&#305;ndan genel prensipler &#351;unlar
olmal&#305;d&#305;r:</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
font-family:Tahoma'>En basit inceleme en �nce yap&#305;lmal&#305;d&#305;r.
Serum takmadan �nce kan ve idrar al&#305;n&#305;p incelenmelidir <b>(Tablo 8)</b>.
Hastalar&#305;n EKG incelemeleri h&#305;zl&#305;ca yap&#305;lmal&#305;d&#305;r.
Akci&#287;er grafisi standart incelemeler aras&#305;nda
unutulmamal&#305;d&#305;r. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
font-family:Tahoma'>Yap&#305;lacak �zg�n incelemeye hasta g�nderilirken mutlaka
ne istedi&#287;imizi bildiren bir not yaz&#305;lmal&#305;, bilgi verilmelidir.
Aksi takdirde inceleme eksik yap&#305;labilir. &#304;ncelemelerin eksik
yap&#305;lmas&#305; tan&#305;da gecikmenin en �nemli unsurlar&#305;ndan
biridir. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
font-family:Tahoma'>Hastan&#305;n klinik durumuna uygun olmayan, en
karma&#351;&#305;k ve uygulamas&#305; zor incelemeler ba&#351;ta
istenmemelidir. Basit, uygulamas&#305; ve yorumu kolay ve standart olan
incelemeler tan&#305;n&#305;n ��z�mlenmesinde genellikle en yararl&#305;
incelemelerdir. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
font-family:Tahoma'>N�rolojik g�r�nt�lemeye bir�ok klinik durumda genellikle
kontrasts&#305;z bir bilgisayarl&#305; tomografi ile
ba&#351;lanmal&#305;d&#305;r. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
font-family:Tahoma'>Acil EEG incelemesi, uyan&#305;kl&#305;k kusuru veya ba&#351;ka
bir nedenle a�&#305;klanamayan davran&#305;&#351; de&#287;i&#351;ikli&#287;i
ile gelen bir hastada klinik olarak g�zden ka�m&#305;&#351; bir n�bet
aktivitesi ve NKSE tan&#305;s&#305;n&#305; koyabilmenin tek yoludur. Baz&#305;
spesifik bulgular&#305;n saptanmas&#305; ile herpes simpleks ensefaliti,
hepatik veya �remik ensefalopati tan&#305;lar&#305;n&#305;n konulmas&#305;na da
yard&#305;mc&#305; olur. �</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
line-height:150%'><span lang=TR style='font-size:10.0pt;line-height:150%;
font-family:Symbol'>�<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=TR style='font-size:12.0pt;line-height:150%;
font-family:Tahoma'>Beyin omurilik s&#305;v&#305;s&#305;n&#305;n (BOS), hem
al&#305;nmas&#305; hem de incelenmesi ve yorumlanmas&#305; bilgi ve
ustal&#305;k ister. Uygun &#351;artlarda al&#305;nmayan (BOS) �rne&#287;i veya
uygun olmayan yorum tan&#305;y&#305; i�inden �&#305;k&#305;lmas&#305; zor bir duruma
getirebilir. Lomber ponksiyon (LP) yap&#305;laca&#287;&#305; s&#305;rada kontrindikasyonlar&#305;
mutlaka g�zden ge�irilmelidir, aksi takdirde tan&#305; koymaya y�nelik bu
inceleme hastan&#305;n hayat&#305;n&#305; tehdit eder duruma gelebilir.
Uyan&#305;kl&#305;k durumu bozuk olan hastalarda, fokal n�rolojik defisiti olan
hastalarda, g�z dibi incelemesinde papil�demi olan olgularda g�r�nt�leme
incelemesi yap&#305;lmadan LP uygulanmamal&#305;d&#305;r. </span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><b><i><span lang=TR style='font-size:12.0pt;
line-height:150%;font-family:Tahoma'>Lezyon hastan&#305;n hayat&#305;
a�&#305;s&#305;ndan bir tehdit olu&#351;turmakta m&#305;d&#305;r? Lezyon
hastan&#305;n n�rolojik i&#351;levi a�&#305;s&#305;ndan bir tehdit olu&#351;turmakta
m&#305;d&#305;r? Etkin bir tedavi yakla&#351;&#305;m&#305; var m&#305;d&#305;r?
En etkin tan&#305; ve tedavi yakla&#351;&#305;m&#305; hangisidir? </span></i></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Acil n�roloji poliklini&#287;inde hastal&#305;k
s�recinin ne oldu&#287;unu tan&#305;mak ne kadar �nemliyse, hangi hastal&#305;k
s�recine h&#305;zl&#305;ca m�dahale edilmesinin gereklili&#287;ini belirlemek
de o denli �nemlidir. �ncelikleri belirlemek amac&#305;yla her hastada mutlaka
hastal&#305;&#287;&#305;n hastan&#305;n ya&#351;am&#305;n&#305; tehdit edip
etmedi&#287;ini, ne h&#305;zla tehdit etti&#287;ini, ya&#351;am&#305;
h&#305;zl&#305;ca tehdit etmiyorsa n�rolojik dizabiliteye yol a�abilme</span><span
lang=TR style='font-size:10.0pt;line-height:150%;font-family:Tahoma'> </span><span
lang=TR style='font-size:12.0pt;line-height:150%;font-family:Tahoma'>potansiyeli
olup olmad&#305;&#287;&#305;n&#305;, �l�m tehdidini ortadan kald&#305;racak
veya dizabiliteyi engelleyebilecek herhangi bir tedavi y�ntemi var olup
olmad&#305;&#287;&#305;n&#305; ve tan&#305; ve tedavi giri&#351;iminin gecikmesinin
prognozu k�t�le&#351;tirip k�t�le&#351;tirmedi&#287;ini sorgulamak
gerekmektedir. </span><span lang=TR style='font-size:10.0pt;line-height:150%;
font-family:Tahoma'>�</span><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Hastalar&#305;n erken tan&#305; ve tedavi
giri&#351;imleri uygulanmazsa hayati tehdit alt&#305;nda oldu&#287;u veya
hayati tehdit alt&#305;nda olmasa da erken tan&#305; ve tedavi giri&#351;imleri
uygulanmazsa n�rolojik dizabilite tehdidi alt&#305;nda oldu&#287;u durumlar tan&#305;
�nceliklerinde hep �n planda tutulmal&#305;d&#305;r. Hekim n�rolojik acil
olaylar kar&#351;&#305;s&#305;nda, her zaman tedavi edilebilme potansiyeli olan
ve h&#305;zl&#305;ca tedavi edilemezse hayat&#305; veya n�rolojik prognozu
tehdit alt&#305;nda tutan tan&#305; olas&#305;l&#305;klar&#305;n&#305; �n
planda tutmal&#305;d&#305;r. <br>
<br>
</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>Acil hekimi hastas&#305;n&#305; de&#287;erlendirirken
kendi bilgi ve beceri da&#287;arc&#305;&#287;&#305; ile ba&#351; ba&#351;ad&#305;r.
Bu da&#287;arc&#305;&#287;&#305; hastas&#305; kar&#351;&#305;s&#305;nda en
yararl&#305; &#351;ekilde kullanma sorumlulu&#287;undad&#305;r. Kural olarak,
en deneyimsiz hekim tan&#305; olas&#305;l&#305;klar&#305; a�&#305;s&#305;ndan
en s&#305;k rastlanan, hayati veya n�rolojik prognoz a�&#305;s&#305;ndan en
tehlikeli hastal&#305;k s�recini �nce d�&#351;�n�p gerekli tan&#305; y�ntemleri
ile bu s�reci ya tan&#305;mal&#305; ya da d&#305;&#351;lamal&#305;d&#305;r.
Bir�ok hastada n�rolojik g�r�nt�leme y�ntemleri tan&#305;da �ok
yard&#305;mc&#305; olacakt&#305;r. Uygun g�r�nt�leme incelemelerinin se�imi ve
h&#305;zl&#305;ca uygulanmas&#305; tan&#305; s�recinin h&#305;zlanmas&#305;n&#305;n,
uygun tedavi y�nteminin se�iminin ve genel olarak daha kaliteli bir bak&#305;m
uygulamas&#305;n&#305;n en �nemli a&#351;amalar&#305;ndan biridir. Bir�ok etiyolojik
tan&#305; olas&#305;l&#305;&#287;&#305;n&#305;n bulundu&#287;u durumlarda
h&#305;zl&#305;ca ay&#305;r&#305;c&#305; tan&#305;ya gidilemiyorsa, hekim
hayati veya n�rolojik i&#351;lev tehdidi a�&#305;s&#305;ndan tedavi
edilebilecek durumlar&#305; hep �n planda tutmal&#305;d&#305;r. <b>Tablo 13</b>�de
bu durumlara ve birincil tedavi yakla&#351;&#305;mlar&#305;na �rnekler
verilmi&#351;tir.</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:35.25pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><span
lang=TR style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>SE bir
n�betin 30 dakikadan uzun s�rmesi ya da bu s�re i�inde hasta d�zelmeden birden
�ok n�betin arka arkaya tekrarlamas&#305; ile karakterizedir. Son y&#305;llarda
bu s�re giderek k&#305;salm&#305;&#351;, baz&#305; yay&#305;nlarda 5 dakikadan
uzun s�ren n�betler bu tan&#305;m i�ine al&#305;nm&#305;&#351;t&#305;r.
Jeneralize konv�lzif status epileptikus (JKSE) en s&#305;k
kar&#351;&#305;la&#351;&#305;lan, en iyi tan&#305;nan ve en tehlikeli tipidir.
En �nemli n�rolojik acil tablolardan birisi olan JKSE tedavi edilmedi&#287;i
takdirde hayat&#305; tehdit eder hale gelir. Bu nedenle acilde b�yle bir tablo
ile kar&#351;&#305;la&#351;&#305;ld&#305;&#287;&#305;nda �ok h&#305;zl&#305;
bir &#351;ekilde tan&#305; konmal&#305;, do&#287;ru tedaviye ba&#351;lanmal&#305;d&#305;r
(Bak&#305;n&#305;z: Epilepsi)� </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:35.25pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><span
lang=TR style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:35.25pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><span
lang=TR style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>Kardiyopulmoner
res�sitasyon sonras&#305; geli&#351;en anoksik koma tablolar&#305;nda spontan
dola&#351;&#305;m sa&#287;land&#305;ktan sonra en �nemli sorun n�rolojik
tablonun k�t� seyretmesi ve buna ba&#287;l&#305; prognozun k�t�
olmas&#305;d&#305;r. N�rolojik geri d�n�&#351;�n ba&#351;ar&#305;l&#305;
olmas&#305;n&#305; sa&#287;lamak i�in terap�tik hipotermi tedavisi son
y&#305;llarda �nemi giderek artarak uygulanmaktad&#305;r (Bak&#305;n&#305;z: Komada
Pratik Tan&#305; ve Tedavi Yakla&#351;&#305;mlar&#305;)</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;line-height:150%'><b><u><span
lang=TR style='font-size:10.0pt;line-height:150%;font-family:Tahoma'><span
 style='text-decoration:none'>&nbsp;</span></span></u></b></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=576
 style='width:432.2pt;border-collapse:collapse;border:none'>
 <tr>
  <td width=576 colspan=2 valign=top style='width:432.2pt;border:none;
  border-bottom:solid windowtext 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoBodyText style='text-align:justify'><b><span lang=TR
  style='font-size:12.0pt;line-height:115%;font-family:Tahoma'>Tablo 13.
  A&#287;&#305;r n�rolojik bir tablo ile ba&#351;vuran hastalarda medikal ve
  cerrahi tedavi yakla&#351;&#305;mlar&#305;</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=576 colspan=2 valign=top style='width:432.2pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <h1 style='text-align:justify'><span lang=TR style='font-size:11.0pt;
  font-family:Tahoma'>Medikal tedavi yakla&#351;&#305;mlar&#305;</span></h1>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify'><b><span lang=TR
  style='font-size:10.0pt;line-height:115%;font-family:Tahoma'>Tan&#305;</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border:none;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify'><b><span lang=TR
  style='font-size:10.0pt;line-height:115%;font-family:Tahoma'>Tedavi</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Ate&#351;</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>-Asetaminofen 500
  mg</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>-NSA&#304;D</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>-periferik
  so&#287;utma</span></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Hipoglisemi</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>50-100cc %50
  Dekstroz IV</span></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Hiponatremi</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>%3 serum salin
  ile 1mEq/L/saatten h&#305;zl&#305; olmamak &#351;art&#305;yla v�cut
  a&#287;&#305;rl&#305;&#287;&#305; x 0.6 x (hedef Na de&#287;eri-serum Na
  de&#287;eri)</span></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Kronik alkolizm</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Parenteral 100 mg
  vit B1</span></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>&#304;ntoksikasyon
  &#351;�phesi</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Semptomatik
  tedaviler: Nalokson, Flumazenil, gastrik lavaj, aktif k�m�r</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Spesifik
  tedaviler</span></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Bakteryel
  menenjit&nbsp;</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Seftriakson 2g IV</span></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Herpes
  simpleks ensefaliti</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Asiklovir 10mg/kg
  IV</span></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>MG</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Asetilkolinesteraz
  inhibit�rleri, intraven�z immunoglob�lin, plazmaferez, mekanik ventilasyon</span></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>GBS</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>&#304;ntraven�z
  immunoglob�lin, plazmaferez, mekanik ventilasyon</span></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Periyodik
  paralizi</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Potasyum
  replasman&#305;</span></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>&#304;skemik
  inme &lt; 4.5 saat&nbsp;</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>rTPA 0,9 mg/kg IV
  (%10 bolus, geri kalan&#305; 1 saatlik inf�zyon)</span></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Status
  epileptikus</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Diazepam 10 mg
  IV� + Difenilhidantoin 18mg/kg</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>25-50mg/dakika
  h&#305;z&#305;nda IV inf�zyon</span></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Kardiyopulmoner
  res�sitasyon sonras&#305; geli&#351;en koma</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Terap�tik
  hipotermi</span></p>
  </td>
 </tr>
 <tr style='height:115.65pt' style='height:115.65pt !msorm'>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  solid windowtext 1.0pt;border-bottom:none;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt;border-top:none !msorm;border-left:solid windowtext 1.0pt !msorm;
  border-bottom:none !msorm;border-right:solid windowtext 1.0pt !msorm;
  padding:0cm 3.5pt 0cm 3.5pt !msorm;height:115.65pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>&#304;ntrakraniyal
  bas&#305;n� art&#305;&#351;&#305; sendromu</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt;border-top:none !msorm;border-left:none !msorm;
  border-bottom:solid windowtext 1.0pt !msorm;border-right:solid windowtext 1.0pt !msorm;
  padding:0cm 3.5pt 0cm 3.5pt !msorm;height:115.65pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>-Hiperventilasyon&nbsp;</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>-%20 Mannitol'den
  1g/kg </span><span lang=TR style='font-size:9.0pt;line-height:150%;
   font-family:Tahoma'>30'</span><span lang=TR style='font-size:9.0pt;
  line-height:150%;font-family:Tahoma'> s�resinde IV inf�zyon</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>-<b><i>T�m�r veya
  inflamatuar kitle �evresinde �dem durumunda</i></b> 12-16 mg Deksametazon IV</span></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <h1 style='text-align:justify'><span lang=TR style='font-size:11.0pt;
  font-family:Tahoma'>Cerrahi tedavi yakla&#351;&#305;mlar&#305;</span></h1>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-family:Tahoma'>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:10.0pt;line-height:150%;font-family:Tahoma'>Tan&#305;</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  background:white;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify'><b><span lang=TR
  style='font-size:10.0pt;line-height:115%;font-family:Tahoma'>Tedavi</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Epidural
  hematom/abse</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Drenaj</span></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Subdural
  hematom/abse</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Drenaj</span></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Geni&#351;
  lober hematom</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Drenaj</span></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Serebellar
  hematom</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>-Drenaj</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>-Hematom
  drenaj&#305; ile birlikte veya yaln&#305;zca arka �ukur dekompresyonu (kranyektomi)</span></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Abse</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Drenaj</span></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Subaraknoid
  kanama</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Uygun grade ise
  anevrizman&#305;n kliplenmesi</span></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Hidrosefali</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Eksternal
  ventrik�ler drenaj</span></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top style='width:216.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
  lang=TR style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>Medulla
  spinalis bas&#305;s&#305;</span></b></p>
  </td>
  <td width=288 valign=top style='width:216.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>-12-16 mg Deksametazon
  IV</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>-Laminektomi</span></p>
  <p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
  style='font-size:9.0pt;line-height:150%;font-family:Tahoma'>-Neoplastik kitle
  durumunda acil radioterapi</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='text-align:justify'><span lang=TR style='font-family:
Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%;page-break-after:avoid'><b><span lang=TR
style='font-size:14.0pt;line-height:150%;font-family:Tahoma'>SONU�</span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>N�rolojik hasar sonras&#305; geli&#351;en sistemik
k&#305;s&#305;r d�ng�n�n �nlenmesi tedavisinden daha kolayd&#305;r ve bunun
i�in gereken s�re de olduk�a s&#305;n&#305;rl&#305;d&#305;r. &#304;leri
kardiyak veya travmal&#305; hasta ya&#351;am deste&#287;inde oldu&#287;u gibi,
&quot;<i>ileri n�rolojik ya&#351;am deste&#287;i yakla&#351;&#305;mlar&#305;</i>&quot;
acil n�roloji prati&#287;inde standart hale gelmelidir. Bu yakla&#351;&#305;m
bir�ok a&#287;&#305;r n�rolojik hastal&#305;k durumunda ortaya �&#305;kan ve
s�rmekte olan n�rolojik hasar&#305;n
s&#305;n&#305;rland&#305;r&#305;lmas&#305;n&#305; sa&#287;layacakt&#305;r. Acil
&#351;artlar&#305;nda k&#305;sa ve �z n�rolojik de&#287;erlendirme
sonras&#305;nda kapsaml&#305; bir hastal&#305;k hikayesi olmadan da destek
tedavileri ba&#351;lat&#305;lmal&#305;d&#305;r. Hayat&#305; ve n�rolojik
fonksiyonu tehdit eden durum ilk �nce tedavi edilmelidir. Kesin tan&#305;ya
ula&#351;&#305;lmam&#305;&#351; olmas&#305;, olas&#305; ve tedavi edilmezse
prognozu k�t�le&#351;tirecek tan&#305;ya y�nelik spesifik tedavinin
ba&#351;lat&#305;lmas&#305;n&#305; geciktirmemelidir.</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:150%'><span lang=TR style='font-size:12.0pt;line-height:
150%;font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span lang=TR style='font-size:12.0pt;font-family:
Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span lang=TR style='font-size:12.0pt;
font-family:Tahoma'>Ba&#351;vuru Kaynaklar&#305;</span></b></p>

<p class=MsoBodyText style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
line-height:normal'><span lang=TR style='font-size:12.0pt;font-family:Tahoma'>1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=TR style='font-size:12.0pt;font-family:Tahoma'>Baykal B. Nonkonv�lzif
Status Epileptikus, &#304;stanbul, Artpres, 2004</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
line-height:normal'><span lang=TR style='font-size:12.0pt;font-family:Tahoma'>2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=TR style='font-size:12.0pt;font-family:Tahoma'>Ropper AH. Neurological and
Neurosurgical Intensive Care, 4. Bask&#305;, Philadelphia Lippincott Williams
&amp; Wilkins, 2004</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
line-height:normal'><span lang=TR style='font-size:12.0pt;font-family:Tahoma'>3.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=TR style='font-size:12.0pt;font-family:Tahoma'>Shah SM, Kelly KM.
Emergency Neurology Principles and Practice, Cambridge, Cambridge University
Press, 1999 </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
line-height:normal'><span lang=TR style='font-size:12.0pt;font-family:Tahoma'>4.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=TR style='font-size:12.0pt;font-family:Tahoma'>Weinner WJ, Shulman LM.
Emergent and Urgent Neurology, 2. Bask&#305;, Philadelphia, Lippincott
Williams, 1999 </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
line-height:normal'><span lang=TR style='font-size:12.0pt;font-family:Tahoma'>5.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=TR style='font-size:12.0pt;font-family:Tahoma'>Wijdicks EFM. Neurologic
Catastrophes in the Emergency Department, Boston, Butterworth Heinemann, 2000</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-36.0pt;
line-height:normal'><span lang=TR style='font-size:12.0pt;font-family:Tahoma'>6.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=TR style='font-size:12.0pt;font-family:Tahoma'>Wijdicks EFM. The Clinical
Practice of Critical Care Neurology, 2. Bask&#305;, New York, Oxford University
Press, 2003. </span></p>

<p class=MsoNormal style='text-align:justify'><span lang=TR style='font-family:
Tahoma'>&nbsp;</span></p>

</div>

</body>

</html>
